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INTRODUCTION
                    Labour is an extremely painful process. Labour pain is of major 
concern since most parturients experience significant pain of extremely severe 
intensity. Labour pain can have deleterious effects on the mother, on the foetus 
and on the labour outcome. Among the current methods of obstetric analgesia, 
regional  analgesia  (the  most  widespread  technique being  epidural  analgesia) 
offers the best effectiveness/safety ratio1.
Epidural anaesthesia is an effective means of providing analgesia during labour. 
The increased availability of epidural analgesia and the favorable experiences of 
women who  have  had  painless  labor  with  epidural  block  have  reshaped  the 
expectations of pregnant women entering labor2.
Compared with other forms of pain relief, epidural analgesia is associated with 
the highest level of maternal satisfaction3. Despite providing excellent pain relief 
during labour, epidural analgesia using local anaesthetic agents alone produce 
motor  block  in  up  to  85%  of  patients,  reduces  maternal  satisfaction  with 
analgesia,  and  is  associated  with  a  prolonged  second  stage  and  increased 
incidence  of  instrumental  delivery.  Epidural  opioids  offer  the  possibility  of 
analgesia without motor block but when used alone do not provide satisfactory 
analgesia throughout labour. Adding an opioid to local anaesthetic solutions can 
2provide effective analgesia with bupivacaine sparing and a reduction in motor 
block4, 5.
The use of either an intermittent bolus or a continuous infusion of local anesthetic 
(with or without an opioid) is considered to provide similar analgesic efficacy and 
no measurable outcome differences3,  6,  7. The addition of an opioid to the local 
anesthetic epidural bolus or infusion has become a highly popular technique, and 
the  combination  is  believed  to  influence  the  duration  and  quality  of  labor 
analgesia.  The  efficacy  and  duration  of  epidural  opioid  alone  is  considered 
inferior to epidural local anesthetic, but the benefits of an opioid should outweigh 
the side effects such as nausea, pruritus, and sedation3, 8, 9. An epidural opioid-
local anesthetic combination may enhance the duration and quality of pain relief 
at less intense motor blockade and contribute to the good progress of labor and 
vaginal delivery3.
                       We conducted this study to compare the efficacy of a mobile 
epidural using 0.125% bupivacaine and 0.0002% fentanyl versus a conventional 
epidural using 0.25% bupivacaine for labour analgesia.
                               
3AIM
 To  compare  the  efficacy  of  epidural  analgesia  using  0.125% 
bupivacaine and 0.0002% fentanyl versus an epidural using 0.25% 
bupivacaine alone for labour analgesia.
The following parameters are compared:
o Quality of analgesia (VAS)
o Duration of labour
o Motor block (Bromage score)
o Time from epidural to delivery
4HISTORY
   Throughout history women suffered with pain until the advent of using ether for 
labour analgesia by Dr.James Young Simpson of Edinburgh on 19th January 
1847, which opened up the interesting avenue of pain relief for labor. At that time 
it was a highly controversial issue10, 11, 12.
Labour  analgesia  became popular  when  John Snow administered  chloroform 
anesthesia to Queen Victoria for the birth of her 8th child Prince Leopold in 1853 
and 9th child Princess Beatrice in 1857. This gave rise to the invention of various 
methods of regional analgesia10, 11, 12. 
Kinkovich  of  St.Petersburg  used  Nitrous  Oxide  in  Obstetric  analgesia  in  1 
880.Guedel designed an apparatus for the self administration of nitrous oxide in 
labor in 191010, 11, 12. 
Dennis Jackson and Striker used Trichloroethylene in 1934. Freedman inhaler 
was developed in 1943 to facilitate administration of analgesic concentrations of 
Trichioroethylene to women in labor10, 12.
Methoxyflurane was used for labor in 1959 and in 1970. Even midwives were 
permitted to use 0.3 5% Methoxyflurane10, 12.
5Tunstall tried Entonox in 1962.Inhalation anesthesia for labor is not much used 
now except Entonox. Following the demonstration of spinal analgesia by August 
Bier in 1899 this was also tried for labor but without much success10, 12.
Stoeckel of Marburg described extradural sacral block in 1909 using Procaine. 
This was followed by Schlimpert and Schneider who used 50m1 of 1% Procaine.
Important  contributions to  the  understanding of  the  anatomical  pathways  and 
physiology  of  labor  pain  were  provided  by  Eugen  Bagden  in  1930  and 
J.G.P.Clealand of University of Oregon in 193310, 12.
Fidel  Pages  of  Spain  performed the  first  lumber  epidural  block  in  1921  and 
Dogliotti of Turin developed the technique in 1930. Refinements in the needle by 
Tuohy and in the catheter quality made continuous epidural analgesia a popular 
technique. The flexibility  introduced by the continuous epidural  technique with 
regard to the duration was especially very suitable for  labour because of the 
longer  duration  required  for  successful  labor  analgesia.  The  CSE  technique 
combines the advantages of both spinal and epidural analgesia10, 12.
The discovery of opioid receptors in the central  nervous system by Snyder in 
1973  and Pert  in  1976  was  soon followed  by  flurry  of  activity.  A  number  of 
opioids have been used successfully both intrathecally and extradurally. Highly 
lipophilic opioids like Fentanyl, Sufentanil and Alfentanil are more suitable than 
6less lipophilic  drugs like morphine.  Opioids provide excellent  pain  relief  when 
used intrathecally or extradurally without affecting the motor system — a property 
which is much desired in an agent used for labour analgesia. Nowadays regional 
analgesia by epidural technique is considered to be the gold standard of labor 
analgesia10, 12.
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ANATOMY OF THE EPIDURAL SPACE
THE EPIDURAL SPACE13
The  epidural  (extradural,  peridural)  space  is  that  part  of  the  vertebral  canal 
external to the duramater and its contents. It lies between the duramater and the 
periosteum lining the canal, and corresponds to the very restricted space within 
the skull between the two layers of the cranial duramater enclosing the venous 
sinuses13.
Figure 1. Epidural space. 
BOUNDARIES
• Anteriorly: By vertebral bodies and posterior longitudinal ligaments
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• Posteriorly: Vertebral arches and ligamentum flavum
• Superiorly: Fusion of dura with periosteum at foramen magnum
• Inferiorly: Sacrococcygeal ligament at sacral hiatus
The epidural space extends from the Foramen magnum to sacral hiatus. Except 
in the lower sacral region it is annular in shape, and narrow. The anterior and 
posterior  nerve  roots  with  their  dural  coverings  pass  across  the  very  narrow 
space to unite in the intervertebral foramen to form the segmental nerves. The 
rest  of  the epidural  space is occupied by numerous small  veins and by fatty 
areolar tissue, which is continuous around the nerves through the intervertebral 
foramina with the fat in the paravertebral spaces. The upward spread of drugs is 
limited  by  the  attachment  of  duramater  to  the  circumference  of  the  foramen 
magnum13.
The amount of fat in the areolar tissue of the space depends on the obesity of the 
subject. It is greatest in the median plane posteriorly where the summit of the 
vertebral arch is commonly separated from the rounded posterior aspect of the 
dura by approximately 5 to 6 mm, and antero-laterally where it is continuous with 
the  pads  of  fat  surrounding  the  spinal  nerves  in  the  intervertebral  foramina. 
Between the postero-lateral walls of the lumbar vertebral canal and the dura, the 
space is narrower, and the fat less evident. Anteriorly in a thin subject, the space 
9
is  only  potential,  since  here  the  dura  lies  close  to  the  posterior  longitudinal 
ligament on the posterior aspect of the vertebral bodies13, 14.
The spread of the local analgesic solution injected into the epidural space is not 
accurately  predictable,  because of  the  resistance offered  by the  fatty  areolar 
tissue and the numerous foramina through which the fluid can leak. A dorso-
median fold of dura mater was demonstrated in a few cases, which sometimes 
divides the epidural space into a ventral and two dorso-lateral compartments, not 
necessarily freely communicating with each other. The median thickness of the 
space might be only 2 mm. These observations explain the occasional patchy 
analgesia and inadvertent dural puncture when the midline approach is used13.
The space occupied by the venous plexus varies with the amount of the venous 
distention  and  is  related  to  the  intra-thoracic  pressure13.
PRESSURE AND VOLUMES OF THE EPIDURAL SPACE
Substantial differences have been observed between the actions of epidural and 
subarachnoid injections of local anaesthetics in the pregnant and non-pregnant 
patient. In many respects the changes are thought to be due to the mechanical 
effects of the pregnancy as the actual size of the space available is reduced. The 
return of blood from the lower part of the body is mainly via the inferior vena 
cava; the epidural veins are also involved and they become dilated. This reduces 
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the space available for the injection of fluid into the epidural space. For the same 
reason, the subarachnoid space is also reduced. As these veins are an alternate 
method of returning lower limb blood flow, their use is maximized if there is an 
obstruction to vena cava return as can happen in pregnancy.
There are three effects from this:
• The volume of local anaesthetic required to provide an extensive block 
is reduced in pregnancy.
• There is an increased risk of puncture of the distended veins by either the 
spinal or epidural needles or the catheter.
• Distension is likely to be maximum in the sitting  position and pressure in 
the epidural space is also increased.
For the above reasons pressure in the epidural space is increased, particularly in 
the  sitting  position.  During  a  contraction,  as  the  blood  expelled  from  the 
contracting  uterus  passes to  the  epidural  venous plexus,  the pressure  in  the 
epidural space may rise by 4-10 cms H20. It is for this reason that injections of 
local anesthetics should be withheld during a contraction, as the spread may be 
unpredictable and probably excessive. Although the engorgement of the epidural 
veins would appear to be increased in the sitting position, there is little evidence 
to suggest that the lateral position is associated with a decrease in complication 
rates such as dural puncture or reduced incidence of venous puncture.
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PHYSIOLOGY OF PAIN IN LABOUR
Pain as described by the International Association for Study of Pain (ISAP) is “an 
unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or as described in terms of such damage”15.
PATHWAYS AND MECHANISM
Pain  perception  by  the  parturient  is  a  dynamic  process  that  involves  both 
peripheral and central mechanisms2, 16.
Many factors have an effect  on the degree of pain experienced by a woman 
during labor, including psychological preparation, emotional support during labor, 
past  experiences,  the  patient's  expectations  of  the  birthing  process,  and 
augmentation of labor with oxytocin. An abnormal presentation (such as occiput-
posterior) may also cause early labor pain to be more intense. There is, however, 
no doubt that for most women, childbirth is associated with very severe pain, and 
it often exceeds all expectations16. A study of women in the first stage of labor 
reported  that  60%  of  primiparous  women  described  the  pain  of  uterine 
contractions  as  being  "unbearable,  intolerable,  extremely  severe,  or 
excruciating"17.
The description of peripheral pain pathways proposed by Cleland in 1993 has 
been modified by Bonica.
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PAIN IN THE FIRST STAGE OF LABOUR
During the  first  stage of  labor,  pain  impulses arise  primarily  from the uterus. 
Uterine contractions may result in myometrial ischemia, which ultimately causes 
the release of bradykinin, histamine, and serotonin. In addition, stretching and 
distention  of  the  lower  uterine  segment  and  cervix  may  stimulate 
mechanoreceptors. These noxious impulses follow the sensory nerve fibers that 
accompany  sympathetic  nerve  endings;  they  travel  through  the  paracervical 
region and the hypogastric plexus to enter the lumbar sympathetic chain18.
Uterine  contractions  cause  stretching,  tearing  and  distortion  and  possibly 
ischemia  of  the  uterine  tissues,  whilst  simultaneously  dilating  the  cervix  and 
stretching  the  lower  uterine  segment.  The  intensity  of  the  pain  increases 
progressively with the raising strength of the contractions. In early labor only the 
nerve  roots  of  T11 and  T12 are  involved,  but  as  the  intensity  of  contractions 
increases, T10 and L1 are recruited18.
Backache is a frequent complaint during labor and may be caused by one or 
other of two mechanisms. Pain originating in the uterus or cervix may be referred 
to  the  cutaneous branches of  the  posterior  divisions  of  T10-L1,  which  migrate 
caudally for an appreciable distance before they innervate the skin overlying the 
vertebral column19. 
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PAIN IN THE SECOND STAGE OF LABOUR
The pain caused by the distension of the pelvic structure and perineum following 
descent  of  the  presenting  part  is  added  to  the  pain  of  uterine  contractions, 
although  once  cervical  dilatation  is  complete  the  pain  induced  by  uterine 
contractions may become less severe2. The uterine pain continues to be referred 
to T10-L1, while the pain produced by stretching or pressure exerted on intrapelvic 
structures, including the peritoneum, bladder, urethra and rectum is referred to 
sacral segments. Pressure on the roots of the lumbosacral plexus may manifest 
itself, as pain felt low in the back or in the thighs. Pain produced by stretching of 
the perineum is  transmitted by the pudendal  nerve  (S2,3,4)  and in  part  by the 
posterior cutaneous nerve of the thigh(S2,3), the genitofemoral nerve (L1,2) and the 
ilio-inguinal nerve (L1)2, 18.
CLINICAL IMPLICATIONS
During the first stage of labour, a block limited to the T11-T12 segments at the 
beginning and later extending to involve T10  and L1 will  usually be sufficient to 
provide  excellent  pain  relief  whilst  avoiding  neural  blockade  of  the  sacral 
segments.  Premature sacral  blockade can result in the loss of the stimulating 
effect upon contractions of Ferguson’s reflex and the loss of pelvic muscle tone, 
which aids the rotation of the presenting part13.
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Later in the first stage and during the early part of the second stage, pain is often 
experienced in lower lumbar and upper sacral segments, so that the block will 
have to be extended if analgesia is to be guaranteed2.  Complete block of the 
sacral  segments  need  to  be  performed  only  when  perineal  pain  becomes 
worrisome. Epidural block will interrupt the preganglionic sympathetic fibres and 
leave the postganglionic fibres intact2.
RELAY OF PAIN13
Pain  from the  peripheral  nociceptive  field  is  transmitted  to  the  cortex  by  the 
afferents arising from the dorsal root ganglion i.e., the first order neurons. The 
majority  of  these  first  order  neurons  passes  to  the  contralateral  side  as  the 
spinothalamic  tract  and  gives  afferents  to  the  medullary  centre,  reticular 
activating system, hypothalamus and reach the post central gyrus in the cortex. 
The efferent impulses reach the segmental area through the corticospinal and 
rubrospinal tracts.
Some of the first order neurons communicate through the intern uncial neurons 
and  give  efferent  impulses  to  the  peripheral  nociceptive  areas  from  the 
segmental autonomic reflexes.
Labor and vaginal delivery produces tissue damage, and like tissue injury from 
any cause, result in pain and local segmental, suprasegmental and cortical 
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responses extended to relieve both uterine pain and pain related to distension of 
the  lower  birth  canal,  thus  providing  analgesia  for  instrumental  delivery  or 
caesarean  sections.  Regional  analgesia  minimizes  or  completely  avoids  the 
problems of  maternal  aspiration,  as well  as neonatal  drug depression due to 
general anesthesia2, 13.
THE STRESS RESPONSE TO PAIN IN LABOUR
Segmental and supra-segmental reflex-responses from the pain of labour may 
affect respiratory, cardiovascular, gastro-intestinal, urinary and neuro-endocrine 
functions.
Respiratory -  Pain  in  labour  initiates  hyperventilation  leading  to  maternal 
hypocarbia,  respiratory  alkalosis  and  subsequent  compensatory  metabolic 
acidosis. The oxygen dissociation curve is shifted to the left and thus reduces 
tissue oxygen transfer, which is already compromised by the increased oxygen 
consumption associated with labour20.
Cardiovascular - Labour results in a progressive increase in maternal cardiac 
output, primarily due to an increase in stroke volume, and, to a lesser extent, 
maternal heart rate. The greatest increase in cardiac output occurs immediately 
after  delivery,  from  the  increased  venous  return  associated  with  relief  of 
venocaval compression and the autotransfusion resulting from uterine involution.
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Hormonal -  Stimulation of pain results in the release of beta-endorphine and 
ACTH from the anterior pituitary. Associated anxiety also initiates further pituitary 
response21.
Pain also stimulates the increased release of both adrenaline and noradrenaline 
from the adrenal  medulla  which  may lead to  a  progressive  rise in  peripheral 
resistance  and  cardiac  output.  Excessive,  sympathetic  activity  may  result  in 
incoordinate  uterine  action,  prolonged  labour  and  abnormal  fetal  heart-rate 
patterns.  Activation  of  the  autonomic  nervous  system  also  delays  gastric 
emptying and reduces intestinal peristalsis.
Metabolic - Maternal: During labour, glucagon, growth hormone, renin and ADH 
level increases while insulin and testosterone level decreases21. Circulating free 
fatty acids and lactate also increase with a peak level at the time of delivery. 
Fetal: Maternal catecholamines secreted as a result of labour pain may cause 
fetal acidosis due to low placental blood flow22.
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PHYSIOLOGICAL CONSIDERATIONS
Maternal  changes  in  pregnancy  occur  as  a  result  of  hormonal  alterations, 
mechanical  effects  of  the  gravid  uterus,  increased  metabolic  and  oxygen 
requirements,  metabolic demands of the fetoplacental  unit,  and hemodynamic 
alterations associated with the placental circulation. Such changes become more 
significant  as  pregnancy  progresses,  and  they  have  major  implications  for 
anesthetic management, especially in high-risk parturients23.
RESPIRATORY SYSTEM
During labour, particularly in the late first stage and second stage, the pain from 
episodic  uterine  contractions  produce  corresponding  increases  in  maternal 
minute ventilation (as much as 300% over  that of  non pregnant women) and 
oxygen consumption23,24. 
The  most  impressive  change  in  maternal  lung  dynamics  is  a  decrease  in 
functional residual capacity (FRC), which at term may have changed by as much 
as 20% of pre-pregnancy values. Minute ventilation increases by 45%, primarily 
as  a  result  of  an  increase  in  tidal  volume  because  the  respiratory  rate  is 
essentially unchanged. Hormonal changes and an increase in the rate of carbon 
dioxide production are responsible for the increase in ventilation. Progesterone 
sensitizes the respiratory center to carbon dioxide. PaCO2 falls to approximately 
30 mm Hg by the 12th week of gestation, and it remains at this level for the 
remainder of pregnancy. Tidal volume increases by 50%, with half of this 
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increase occurring during the first  trimester.  The parturient's breathing pattern 
changes; it becomes more diaphragmatic as pregnancy progresses because of 
the effects of the gravid uterus and limitation of thoracic cage movement. Closing 
capacity (CC), however, remains unchanged. The resulting decrease in the FRC/
CC ratio causes faster small-airway closure when lung volume is reduced; thus, 
parturients can desaturate at a much faster rate than nonpregnant women can. 
The  rapid  development  of  hypoxia  as  a  result  of  decreased  FRC,  increased 
oxygen consumption, and airway closure may be minimized by administration of 
100%  oxygen  for  3  to  5  minutes  before  the  induction  of  anesthesia.  In  an 
emergency setting, four maximal capacity breaths with 100% oxygen should be 
sufficient23.
During pregnancy, capillary engorgement of the mucosa occurs throughout the 
respiratory  tract,  potentially  causing  edema  in  the  nasopharynx,  oropharynx, 
larynx and trachea. Therefore, manipulation of the upper airway requires extreme 
care. Regional analgesia abolishes the requirement of airway manipulation and 
hence avoids the dangers involved in general anesthesia23.
CARDIOVASCULAR CHANGES
The  cardiovascular  system  is  progressively  stressed  during  pregnancy  and 
parturition. Many of the changes appear during the first trimester of pregnancy 
increases in cardiac output of 22% and decrease in systemic vascular resistance 
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by 30% at 8 weeks gestation). The changes continue into the second and early 
third  trimester  of  pregnancy,  when  cardiac  output  increases to  approximately 
30-40% of non-pregnant values. The increase in cardiac output during pregnancy 
is primarily a result of increase in stroke volume (by about 30%) with a more 
modest increase in heart rate(10-15 beats/mm). Arterial blood pressure does not 
change during normal pregnancy because of a decrease in peripheral vascular 
resistance23.
Parameter Change Amount (%)
Heart rate Increased 20–30
Stroke volume Increased 20–50
Cardiac output Increased 30–50
Contractility Variable ±10
Central venous pressure Unchanged —
Pulmonary  capillary  wedge 
pressure Unchanged —
Systemic vascular resistance Decreased 20
Systemic blood pressure Slight decrease
Mid-trimester 10–15 mm Hg, 
then rises
Pulmonary vascular resistance Decreased 30
Pulmonary artery pressure Slight decrease —
Table 1   -- Cardiovascular changes in pregnancy
Clinical  examination of  a  pregnant  woman may reveal  a  wide,  loud split  first 
sound and a soft ejection systolic murmur, caused by the increased blood flow 
and vasodilatation.  The elevated  diaphragm usually  alters  the  position of  the 
heart at term, so that the point of maximum impulse is felt a little to the left. The 
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axis on the ECG is also shifted to left. ECG may show non-specific ST, T and Q 
wave changes and benign arrhythmias23.
The pain and apprehension of labor adds to cardiac work during pregnancy and 
increases stroke volume and cardiac output by 45% over prelabour values. Blood 
pressure  increases  during  painful  labor.  Additional  stresses  are  imposed  by 
uterine contractions, which cause, in effect an autotransfusion. With each uterine 
contraction,  blood  from  the  body  of  the  uterus  is  pushed  into  the  central 
circulation  and  blood  volume  and  cardiac  output  increase  by  10-25%.  After 
delivery also the same auto transfusion occurs. In addition to increase in central 
blood volume,  obstruction of  the venacava is  relieved.  As a result  there is  a 
marked increase (upto 80% of pre labor values) in stroke volume and cardiac 
output in the immediate post partum. Patients with limited cardiac reserve may 
experience cardiac failure at this time23.
Despite the increase in blood volume and cardiac output, the parturient at term is 
susceptible to hypotension in supine position. ‘When the patient is supine, the 
gravid  uterus  partially  or  completely  compresses  the  aorta  and  inferior  vena 
cava,  leading  to  decreased  venous  return,  decreased  cardiac  output, 
hypotension and reduced uterine blood flow. Up to 10% of pregnant patients near 
term develop signs of shock (hypotension, pallor, sweating, nausea, vomiting, 
changes in cerebration) when they assume this position. Compensatory 
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mechanisms  include  increased  sympathetic  tone  and  collateral  routes 
(paravertebral veins to azygos vein) to improve venous return during obstruction 
of  the  vena  cava.  Caval  compression  also  increases  uterine  venous  back 
pressure, which further decreases uterine blood flow. Compression of the aorta is 
not associated with maternal symptoms but does cause arterial hypotension in 
the lower  extremities and uterine arteries,  which can further decrease uterine 
blood flow and impair utero-placental perfusion23.
The  anesthesiologist  must  recognize  the  importance  of  the  aortocaval 
compression  syndrome  and  the  potential  for  its  adverse  effects  to  be 
exaggerated  by  anaesthesia.  Drugs  causing  vasodilatation  such  as  potent 
inhalational agents and particularly anesthetic techniques causing sympathetic 
blockade (subarachnoid or epidural anesthesia) exacerbate decreased venous 
return to the heart when the vena cava is obstructed. Aortocaval compression 
must be prevented.  Displacement of  the uterus, off  the great vessels can be 
accomplished by manually displacing the uterus to the left.  During labour the 
patient should be positioned either on her side or with a left tilt. During delivery 
the operating or the delivery table can be tilted laterally to the left  or a small 
pillow or foam rubber wedge can be used to elevate the patient’s right buttock 
and back to about 10-15 cms23.
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The pregnant woman at term is in a hypercoagulable state owing to increase in 
factors VII,  VIII,  X and plasma fibrinogen. Estimation of blood loss at delivery 
vary but may be around 500ml for an uncomplicated vaginal delivery. Blood loss 
during caesarean section varies widely with 500 to 1400 ml, being reported23.
HEPATIC CHANGES
Total  protein  concentration  and  the  albumin-  globulin  concentration  ratio 
decrease. Although plasma cholinesterase activity is reduced during pregnancy 
and in the immediate post partum period, moderate doses of Succinylcholine are 
usually metabolized easily23.
GASTRO INTESTINAL CHANGES
During pregnancy, the secretion of gastric acid increases. During late pregnancy, 
gastric emptying is slowed as a result of displacement of pylorus by the enlarged 
uterus.  Pain,  anxiety  and  use  of  opioid  analgesia  during  labor  contribute  to 
impaired  gastric  emptying.  Intra-gastric  pressure  is  increased  and  lower 
oesopahgeal sphincter tone is decreased during pregnancy. All these changes 
increase  the  risk  of  regurgitation  and  aspiration  during  either  during  general 
anaesthesia  or  during  the  state  of  impaired  consciousness  from  any  other 
cause23.
23
CENTRAL NERVOUS SYSTEM CHANGES
Pregnancy reduces anesthetic  requirements  both during regional  and general 
anesthesia. During spinal or epidural anesthesia, less local anesthetic is required 
to  produce  a  given  level  of  anesthesia.  This  was  thought  to  be  due  to  the 
mechanical  effects  of  increased  intra-abdominal  pressure,  causing  epidural 
venous engorgement  and a  reduction  of  both  the  epidural  and subarachnoid 
spaces.  Reduced  MAC  is  seen  during  early  pregnancy  and  immediate  post 
partum period23.
RENAL CHANGES
Renal blood flow and glomerular filtration rate increase rapidly during pregnancy, 
reflecting changes in cardiac output. During the third trimester, they slowly return 
to normal. Creatinine clearance usually increases and therefore the upper limits 
of normal for blood urea nitrogen and serum creatinine are lower in the pregnant 
woman23.
UTERINE BLOOD FLOW
Uterine blood flow in the parturient at term is approximately 700ml/min and is 
determined by the following relationship:
Uterine blood flow = (Uterine arterial pressure)-(Uterine venous pressure)
                                            (Uterine vascular resistance)
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There is autoregulation of uterine blood flow. The vessels are maximally dilated 
during pregnancy. As such in the absence of aortic compression, uterine arterial 
pressure directly reflects maternal  blood pressure and cardiac output.  Uterine 
blood  flow  decreases  during  maternal  hypotension  (sympathetic  block, 
hypovolemia,  haemorrhage,  compression  of  the  inferior  vena  cava),  in 
circumstances in which uterine venous pressure is increased (compression of the 
inferior  venacava,  abruption  placenta),  and with  increases in  uterine  vascular 
resistance  (maternal  hypertensive  disorders,  a  agonists,  uterine 
hypercontractility).  Due  to  increased  maternal  mean  arterial  pressure  and  a 
concomitant decrease in uterine blood flow there are deleterious effects on the 
foetus.  After  epidural  analgesia  uterine  blood  flow  increases,  mean  arterial 
pressure stabilizes and placental blood flow is increased by either a reduction in 
extrinsic  vascular  tone  (uterine  tone)  or  a  decrease  in  intrinsic  vascular 
resistance (placental vasodilatation). Conditions that increase the frequency or 
duration  of  uterine  contractions  (e.g.  an  over  dose  of  oxytocin  or  abruption 
placentae) also decrease uterine blood flow23.
EFFECTS OF LABOUR PAIN ON THE FOETUS
During uterine contractions there is intermittent reduction of the intervillous blood 
flow and during a peak of contraction, there may be a temporary decrease in the 
placental gas exchange. This is worsened by maternal hyperventilation due to 
severe pain. Respiratory alkalosis in the mother results in the following:
25
 A  shift  of  the  mother’s  oxygen  dissociation  curve  to  the  left, 
diminishing transfer of oxygen form mother to the fetus.
 Maternal hypoxia during uterine relaxation.
 Umbilical vasoconstriction causing a diminution of umbilical blood flow.
 A  reduction  in  uterine  blood  flow  due  to  elevations  in  noradrenalin 
levels.
 Fetal hypoxia
Normally maternal blood receives acid metabolites and carbon dioxide from fetal 
blood and the pH decreases so that there is shift in the maternal oxyhaemoglobin 
dissociation to the right maintaining increased oxygen delivery to the fetus. At the 
same time in  fetal  blood,  the pH increases leading to  a  shift  in  fetal  oxygen 
dissociation curve to the left. This effect is known as the double Bohr effect. In 
prolonged labor maternal hyperventilation leads to alkalosis and with diminishing 
maternal  PaCO2,  the  Bohr  effect  may  be  attenuated  and  cause  hypoxia  in 
conditions  of  fetal  stress.  Thus  maternal  hyperventilation  as  a  result  of  pain 
decreases  fetal  oxygenation,  presumably  by  shifting  the  maternal  oxygen 
dissociation curve to the left and by reducing umbilical blood flow.
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EPIDURAL LABOUR ANALGESIA
Lumbar epidural analgesia offers a safe and effective method of pain relief during 
laboUr. It is versatile and may be extended to provide anesthesia for instrumental 
or operative delivery. Low doses of local anesthetic or opioid combinations are 
administered (usually by infusion) to provide a continuous T10-L1 sensory block 
during the first stage of labor. Further supplementation may be required during 
the late first stage and second stage to achieve a sacral block2, 23. 
The benefits of epidural analgesia include effective pain relief without appreciable 
motor  block,  reduction  in  maternal  catecholamines,  and  a  means  to  rapidly 
achieve  surgical  anesthesia2,  23.  Despite  numerous  relative  contraindications, 
there  are  very  few  absolute  contraindications  to  neuraxial  analgesia.  Such 
contraindications  include  patient  refusal,  overt  maternal  coagulopathy,  frank 
infection at the needle site, and maternal haemodynamic instability. Other high-
risk conditions, such as fixed cardiac output states (critical aortic stenosis), must 
be considered on a case-by-case basis, thereby allowing a risk-benefit analysis 
for each patient2, 23.
Timing Considerations 
It  is  uncommon  for  spontaneously  laboring  parturients  to  request  epidural 
analgesia  before  3  cm  of  cervical  dilation2.  However,  women  receiving 
augmentation of labor with oxytocin may request analgesia at minimal cervical 
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dilation. It is appropriate to induce epidural analgesia after the diagnosis of active 
labor  has been established and the patient  has begun to  request  pain  relief. 
While epidural block is not contraindicated in advanced labor, it is less common 
to  initiate  epidural  block  when  cervical  dilation  exceeds  8  cm--especially  in 
parous women25, 26.
Complications of Epidural Analgesia  
 
Immediate
• Hypotension (systolic blood pressure <100 mm Hg or a decrease of 25 
percent below preblock average)
• Urinary retention
• Local anestheticinduced convulsions*
• Local anestheticinduced cardiac arrest*
Delayed
• Postdural puncture headache
• Transient backache
• Epidural abscess or meningitis*
• Permanent neurologic deficit*
Note:   *--Very rare. 
 
Induction and Maintenance of Analgesia 
A  method  of  administering  epidural  analgesia  is  outlined  in  Figure  2.  The 
anesthesiologist's  goal  during  the  first  stage  of  labor  should  be  to  provide 
segmental sensory anesthesia of the T10-L1 dermatomes. The dose of local 
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anesthetic  necessary  to  achieve  effective  labor  analgesia  will  depend on the 
intensity and location of the patient's pain. These in turn depend on the variables 
discussed earlier, including the amount and rate of cervical dilation; the strength, 
frequency and duration of uterine contractions; and the position of the fetal head 
at the time epidural analgesia is requested. Approximately 10 mL of 0.125 to 0.25 
percent bupivacaine or 0.125 to 0.25 percent ropivacaine, with or without a small 
dose of a lipid-soluble opioid (e.g., fentanyl or sufentanil), establishes effective 
analgesia  with  minimal  motor  block.  Thereafter,  maintenance  of  epidural 
analgesia may be achieved with either intermittent bolus injections, continuous 
epidural  infusion  or  patient-controlled  epidural  analgesia.  In  most  cases, 
analgesia may be maintained with a solution of local anesthetic more dilute than 
that used for induction2, 27. 
The supine  position  is  contraindicated  in  women receiving  epidural  analgesia 
during labor.  Compression of  the abdominal  aorta and the inferior  vena cava 
(aortocaval compression) by the term gravid uterus may concurrently decrease 
uterine arterial  pressure and increase uterine venous pressure. Consequently, 
uterine  perfusion  pressure  (uterine  arterial  pressure  minus  uterine  venous 
pressure) may be substantially reduced even in the presence of normal brachial 
arterial  blood  pressure  measurements  (concealed  aortocaval  compression). 
When maternal hypotension occurs during epidural analgesia, it is essential to 
verify that the patient is not supine2. 
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Figure 2. Technique of lumbar epidural puncture by the midline approach. 
A, This side view shows left hand held against patient's back, with thumb and index 
finger  grasping  hub.  Attempts  to  inject  solution  while  point  of  needle  is  in  the 
interspinous ligament meet resistance.
 B, Point of needle is in the ligamentum flavum, which offers marked resistance and 
makes it almost impossible to inject solution. 
C, Entrance of the needle's point into epidural  space is discerned by sudden lack of 
resistance to injection of saline. Force of injected solution pushes dura-arachnoid away 
from point of needle. 
D, Catheter  is  introduced through needle.  Note that  hub of  needle  is  pulled  caudad 
toward the patient, increasing the angle between the shaft of the needle and the epidural 
space. Also note technique of holding the tubing: It is wound around the right hand. 
E, Needle is withdrawn over tubing and held steady with the right hand. 
F, Catheter is immobilized with adhesive tape. Note the large loop made by the catheter 
to decrease risk of kinking at the point where the tube exits from the skin. 
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The  onset  of  fetal  descent  causes  substantial  distention  of  the  vagina  and 
perineum, typically  resulting in  severe pain.  It  is  important to  ensure that  the 
segmental extent of epidural analgesia has spread to include the S2-4 nerve roots 
to  maintain analgesia during this stage of  labor.  Achieving adequate perineal 
analgesia is especially important in women in whom episiotomy or the application 
of forceps is probable. Complaints of rectal pressure with progressive descent of 
the fetal  head should alert  the anesthesiologist  that  sacral  analgesia  may be 
inadequate for  delivery.  Women who progress into the second stage of labor 
soon after induction of epidural analgesia seldom have adequate sacral blockade 
and often require additional epidural boluses of local anesthetic before delivery. 
On  the  other  hand,  women  who  have  been  receiving  continuous  epidural 
analgesia for many hours often have excellent perineal analgesia at delivery2.
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PHARMACOLOGY OF BUPIVACAINE 28
Bupivacaine hydrochloride is a long-acting local anesthetic of the amide type.
HISTORY
It is an amide linked local anesthetic synthesized by B.A.F Ekenstam in 1957 and 
introduced into clinical practice by Talivuo in 1963.
STRUCTURE
Bupivacaine HCl which is chemically designated as 2-piperidinecarboxamide, 1-
butyl-N-(2,6-dimethylphenyl)-,  monohydrochloride,  monohydrate  and  has  the 
following structure:
CHEMISTRY
Bupivacaine occurs as a 50:50 racemic mixture of the R- and S-enantiomers and 
is commercially available as bupivacaine and levobupivacaine, the S-enantiomer 
of bupivacaine. Bupivacaine hydrochloride is a local anesthetic of the amide type 
with a long duration of action. Bupivacaine hydrochloride differs structurally from 
mepivacaine hydrochloride only in the substitution of  a butyl  group for the N-
methyl group. Bupivacaine hydrochloride occurs as a white, odorless, crystalline 
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powder and is freely soluble in water and in alcohol. The pKa of bupivacaine 
hydrochloride is 8.128.
MECHANISM OF ACTION
The  base  form  is  in  equilibrium  with  cationic  form  outside  the  axoplasmic 
membrane. Base form diffuses inside the cell and recalibrates with cationic form. 
It  then reaches the  local  anesthetic  receptor  in  the  Na channel  by reversing 
channel  pore  while  it  is  in  an  open  state.  It  prevents  Na  ions  moving 
intracellularly. In addition to this simple sodium channel blockade, it also affects 
second messenger system such as adenylate cyclase and guanylate cyclase and 
also inhibits synaptic transmission by modification of post synaptic receptor (or) 
presynaptic calcium channel blockade in epidural / subarachnoid blockade.
PHYSIOCHEMICAL PROPERTIES
Property Value
Molecular weight 288
Potency ratio 15
Toxicity ratio 10
pKa (25.C) 8.16
Protein binding in %
Maternal 95
Fetal 66
% non ionized at
pH 7.4 17
pH 7.2 11
Partition co-efficient
(25.C,pH7.4) 346
Anesthetic index 3.0-4.0
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PHARMACOKINETICS OF EPIDURAL BUPIVACAINE28
The uptake of local anesthetic into blood vessels in the area where it has been 
deposited and its subsequent transfer into systemic circulation is referred to as 
systemic absorption.
ABSORPTION
A biphasic absorption pattern has been found for epidural bupivacaine. The rapid 
initial absorption following epidural administration is most likely related to high 
concentration  gradient  between  the  drug in  the  solution  and in  the  blood.  In 
addition  profound  increases  in  epidural  blood  flow  observed  during  epidural 
administration of  bupivacaine may contribute to  its  fast  initial  absorption rate. 
Later on, after the local anaesthetic has been taken up into local tissues such as 
epidural  fat,  absorption  will  become  dependent  on  tissue  blood  partitioning, 
resulting in marked slowing of absorption. Estimated total fraction of the dose 
ultimately absorbed into general circulation is 0.94 with mean absorption time 8.6 
hours.
Absorption of local anesthetic is directly related to the amount of drug injected, 
vascularity,  site injected and tissue binding of local anesthetic at injection site. 
Bupivacaine  will  produce  lower  Cmax than  less  potent  and  less  lipid  soluble 
agents.
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DISTRIBUTION
Distribution  of  local  anesthetic  has  special  emphasis  in  the  pregnant  patient, 
because  one  of  the  organs  that  will  be  exposed  to  the  absorbed  drug  is 
fetoplacental unit.
PHARMACOKINETICS OF BUPIVACAINE
Elimination half life t½ - 162 minutes
Volume of distribution VDSS - 73 lit
Clearance (lit/min) - 0.6
Hepatic extraction - 0.4
BIODEGRADATION AND ELIMINATION
Liver is the site of metabolism. Two major factors controlling the clearance of the 
amide linked local anesthetic are hepatic blood flow and hepatic function. The 
principal  pathways  are  N-dealkylation,  aromatic  hydroxylation  and  amide 
hydrolysis.
CLINICAL CHARACTERISTICS OF BUPIVACAINE
Property Value
Penetrance Moderate
Duration 6-8 hrs
Infiltration 0.05%
Field block 0.1%
Pudendal/paracervical 0.125%
Epidural analgesia 0.125-0.25%
Extradural motor 0.5-0.75%
Maximal dose 2mg/kg body weight
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ADVERSE EFFECT AND COMPLICATIONS28
Central Nervous System Toxicity
Potentially toxic blood level can occur when a drug is injected intravenously, intra 
arterially or a large dose of drug is given into highly vascular area. Risk of CNS 
toxicity is more because bupivacaine is a highly protein bound drug. Pregnancy 
is associated with 30% reduction in protein binding. This allows for higher brain 
level of bupivacaine for a given dose of drug.
Symptoms
Slow speech, jerky movements, tremors, hallucination, and seizure.
Cardiovascular Toxicity29, 30
1. Dose dependant depression of contractility
2. Dose dependent depression of conduction and velocity in all conducting 
tissues. Progressive prolongation of ventricular conduction.
3. Predisposition  to  reentry  phenomenon  followed  by  sudden  onset  of 
ventricular fibrillation.
4. More affinity for cardiolipin
Toxic plasma concentration is 4-5 µg/ml
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PHARMACOLOGY OF FENTANYL31
Fentanyl is a synthetic phenylpiperidine-derivative opiate agonist.
STRUCTURE
Fentanyl  citrate  is  N-(1-Phenethyl-4-  piperidyl)  propionanilide  citrate  (1:1). 
Fentanyl is a highly lipophilic compound that is freely soluble in organic solvents 
and sparingly soluble in water (1:40). The molecular weight of the free base is 
336.5 (the citrate salt is 528.6). The pKa of the tertiary nitrogens are 7.3 and 8.4. 
The compound has the following structural formula:
PHARMACODYNAMICS OF FENTANYL31
CARDIOVASCULAR SYSTEM
Bradycardia — vagal stimulation in high doses.
No effect on cardiac contractility
Hypotension in large doses due to bradycardia, venodilation and suppression of 
central sympathetic out flow.
RESPIRATORY SYSTEM
Dose  dependent  respiratory  depression  through  direct  action  on  medullary 
respiratory centre.
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Apnoeic threshold increased.
Hypoxic drive decreased
Delayed respiratory depression.
CENTRAL NERVOUS SYSTEM
Analgesia, euphoria, sedation, hyponosis, miosis, nausea, vomiting.
Gastrointestinal tract: Delays gastric emptying, produces biliary colic.
Endocrine system: Attenuation of stress response
PHARMACOKINETIC / PHYSIOCOCHEMICAL PROPERTIES
Property Value
pKa 8.4
% unionized at pH 7.4 <10
Percentage bound to plasma protein 84
t ½ µ l-2mins
t ½ α 10-30mins
t ½ β 2-4hour
Vdcc L/kg 0.5 - 1.0 L /Kg
Vdss L/kg 3-5 L/kg
Clearance 10-20 mI/kg/mt
Hepatic extraction ratio 0.8-1.0
CLINICAL PROPERTIES
o Minimal CSF spread
o Rapid onset
o Short duration
o Low CSF solubility Rapid analgesia
o Decreased side effects
o Ideal for PCEA
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DISADVANTAGES
o Systemic absorption
o Brief single dose analgesia
When applied intraspinally these opioids should be injected as close as possible 
to  the  spinal  segments  where  the  previous  nociceptive  afferent,  carrying  the 
nociceptive impulses from the involved dermatomes enter the spinal cord. When 
this is accomplished small doses of the drug will produce significant analgesia.
PHARMACOLOGY OF EPIDURAL FENTANYL
Dose = 50 -200 µg
Onset            = 5—15 minutes
Duration = 2 —4 hours after single dose
SIDE EFFECTS
Pruritus, sedation, nausea and vomiting, urinary retention, apnoea and seizures, 
chest wall rigidity.
FACTORS ASSOCIATED WITH RESPIRATORY DEPRESSION
Elderly,  poor  general  condition,  concomitant  use  of  other  drugs  (CNS 
depressants), the use of hydrophilic opioids.
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REVIEW OF LITERATURE
1.  Comparison of epidural bolus administration of 0.25% bupivacaine and  
0.1% bupivacaine with 0.0002% fentanyl for analgesia during labour5.
In  a double-blind,  randomized,  controlled study,  comparison of  epidural  bolus 
administration  of  0.25%  bupivacaine  and  0.1%  bupivacaine  with  0.0002% 
fentanyl for analgesia during labour was done. Patients were randomized to enter 
either group A treatment arm or group B treatment arm. Group A received 10-ml 
bolus doses of 0.1% bupivacaine with fentanyl 2 micrograms/ml while group B 
received 0.25% plain bupivacaine 10 ml. Analgesia provided by both techniques 
was found to be similar. Women in group A retained motor power in their legs 
and 60% chose to get out of bed. Duration of labour and time from insertion of 
the epidural to delivery was similar in both groups, but in group A, duration of the 
second stage was significantly shorter (p = 0.0003; 95% confidence interval (CI) 
-1.17, -0.27 h) and the incidence of forceps delivery was lower (p = 0.032). In 
addition, maternal satisfaction with epidural analgesia, as assessed by VAS, was 
higher in group A (p = 0.04; 95% CI -0.001, 10.001)5.
2.  A  comparison  of  minimum  local  anesthetic  volumes  and  doses  of  
epidural bupivacaine (0.125% w/v and 0.25% w/v) for analgesia in labor32.
Bupivacaine 0.125% (w/v) when compared with 0.25% (w/v) produced equivalent 
analgesia with a 50% increase in volume, but with a 25% reduction in dose. Any 
reduction in dose, without loss of efficacy, reduces risk of toxicity and improves 
safety32. A study was conducted to determine and compare the minimum local 
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anesthetic  volumes  (MLAV)  and  doses  (MLAD)  of  two  concentrations  of 
bupivacaine for epidural pain relief in labor, and to quantify the effect on dose. 
Eighty women were randomized in a double-blind manner to receive a first bolus 
of either plain bupivacaine 0.125% (w/v) or 0.25% (w/v). The arbitrary starting 
volume was 15 mL. Subsequent volumes were decided by sequential allocation 
according to  analgesic  efficacy.  A visual  analog pain  score < or  =10 (0-100) 
within  30  min,  indicated  effective  analgesia.  The  next  woman  received  a 
decrement of 2 mL. A failure of the visual analog pain score to reach < or =10 
was followed by a 2 mL increment for the next woman.  Using the formula of 
Dixon and Massey, MLAV and MLAD, with 95% confidence intervals (CI) were 
calculated for each concentration. MLAV was 13.6 mL (95% CI 12.4-14.8), with 
bupivacaine 0.125% (w/v), and 9.2 mL (95% CI 6.9-11.5) with bupivacaine 0.25% 
(w/v). The difference was highly significant (P = 0.002). MLAD for these volumes 
were 17.0 mg (95% CI 15.5-18.5), and 23.1 mg (17.2-28.9), respectively (p = 
0.045)32. 
3.  A randomized comparison of  programmed intermittent  epidural  bolus 
with continuous epidural infusion for labor analgesia33.
Bolus injection through an epidural catheter may result in better distribution of 
anesthetic solution in the epidural space compared with continuous infusion of 
the same anesthetic solution33. In a randomized, double-blind study, comparison 
of total bupivacaine consumption, need for supplemental epidural analgesia, 
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quality  of  analgesia,  and  patient  satisfaction  were  assessed  in  women  who 
received  programmed  intermittent  epidural  boluses  (PIEB)  compared  with 
continuous  epidural  infusion  (CEI)  for  maintenance  of  labor  analgesia.  The 
primary outcome variable was bupivacaine consumption per hour of analgesia. 
Combined spinal  epidural  analgesia  was  initiated  in  multiparas  scheduled  for 
induction  of  labor  with  cervical  dilation  between  2  and  5  cm.  Subjects  were 
randomized  to  PIEB  (6-mL  bolus  every  30  min  beginning  45  min  after  the 
intrathecal  injection)  or  CEI  (12-mL/h infusion beginning 15 min the after  the 
intrathecal injection). The epidural analgesia solution was bupivacaine 0.625 mg/
mL and fentanyl  2 microg/mL. Breakthrough pain in both groups was treated 
initially  with  patient-controlled  epidural  analgesia  (PCEA)  followed  by  manual 
bolus rescue analgesia using bupivacaine 0.125%. The median total bupivacaine 
dose per  hour  of  analgesia  was  less in  the PIEB (n =  63)  (10.5 mg/h;  95% 
confidence interval, 9.5-11.8 mg/h) compared with the CEI group (n = 63) (12.3 
mg/h; 95% confidence interval, 10.5-14.0 mg/h) (p < 0.01), fewer manual rescue 
boluses  were  required  (rate  difference  22%,  95%  confidence  interval  of 
difference 5% to 38%), and satisfaction scores were higher. Labor pain, PCEA 
requests, and delivered PCEA doses did not differ. PIEB combined with PCEA 
provided  similar  analgesia,  but  with  a  smaller  bupivacaine  dose  and  better 
patient satisfaction compared with CEI with PCEA for maintenance of epidural 
labor analgesia33.
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4. 0.125% ropivacaine is similar to 0.125% bupivacaine for labor analgesia 
using patient-controlled epidural infusion34.
0.125% ropivacaine is similar to 0.125% bupivacaine for labor analgesia using 
patient-controlled epidural  infusion34.  A study compared the effects of  0.125% 
ropivacaine with 0.125% bupivacaine in laboring patients using patient-controlled 
epidural analgesia (PCEA). Fifty-one ASA physical status I or II term parturients 
with  functioning epidural  catheters were randomized to receive ropivacaine or 
bupivacaine using a prospective, double-blind design. Basal infusions (6 mL/h) 
were  supplemented  with  patient-controlled  boluses  (5  mL)  every  10  min  as 
required. For inadequate analgesia, patients were administered 10-mL boluses of 
study solution until comfortable. There were no differences in verbal pain scores, 
amount of local anesthetics used, sensory levels, motor blockade, labor duration, 
mode  of  delivery,  side  effects,  or  patient  satisfaction  between  the  two  local 
anesthetics.  Results  showed  that  0.125%  ropivacaine  and  bupivacaine  are 
clinically indistinguishable and are both highly effective for labor analgesia using 
PCEA34. 
5. Local anesthetics and mode of delivery: bupivacaine versus ropivacaine 
versus levobupivacaine35.
Bupivacaine, ropivacaine, and levobupivacaine all confer adequate labor epidural 
analgesia, with no significant influence on mode of delivery, duration of labor, or 
neonatal outcome35. A clinical study was conducted to determine if there is a 
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difference  in  mode  of  delivery  among  parturients  who  receive  epidural 
bupivacaine,  ropivacaine,  or  levobupivacaine.  Nulliparous  women  at  term 
requesting labor analgesia with  a cervical  dilation <5 cm were randomized to 
receive  epidural  bupivacaine,  ropivacaine,  or  levobupivacaine.  Analgesia  was 
initiated with a bolus of 15 mL of 0.0625% of the assigned LA with fentanyl 2 
microg/mL. Analgesia was maintained with an infusion of the same solution at 10 
mL/h.  The  primary  endpoint  was  the  operative  delivery  rate  (instrumental 
assisted vaginal delivery plus cesarean delivery). Ninety-eight women received 
bupivacaine, 90 ropivacaine, and 34 levobupivacaine. There was no significant 
difference in the operative delivery rate (bupivacaine = 46%, ropivacaine = 39%, 
and levobupivacaine = 32%, p = 0.35) among groups. There was less motor 
block in  the levobupivacaine group when compared with  the ropivacaine and 
bupivacaine groups, p < 0.05. There was no significant difference in the duration 
of the first or second stage of labor, the total dose of LA received per hour of 
labor, or neonatal outcome among groups35. 
6.  Rates  of  caesarean  section  and  instrumental  vaginal  delivery  in 
nulliparous  women after  low concentration  epidural  infusions  or  opioid  
analgesia: systematic review36.
Epidural analgesia using low concentration infusions of bupivacaine is unlikely to 
increase the risk of caesarean section but may increase the risk of instrumental 
vaginal  delivery.  Although  women  receiving  epidural  analgesia  had  a  longer 
second stage of labour, they had better pain relief36.
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7. The site of action of epidural fentanyl infusions in the presence of local  
anesthetics:  a  minimum local  analgesic  concentration infusion  study  in  
nulliparous labor37.
Coadministered  epidural  fentanyl  infusions  were  more  than three  times more 
potent than IV fentanyl infusions, suggesting a predominantly spinal mechanism 
of opioid action37. Forty-eight nulliparous women in active labor participated in a 
prospective, randomized, double-blinded study. Women received lumbar epidural 
analgesia with 20-30 mL bupivacaine 0.125% until pain free. Subjects were then 
randomized to either IV or epidural (EPI) fentanyl infusion groups. Each infusion 
delivered fentanyl 30 micrograms/h. All women received an epidural infusion of 
bupivacaine at a rate of 20 mL/h, the concentration of which was determined by 
the response of the previous woman in the same group to the analgesic regimen 
used.  Unlike  previous  studies  that  assessed  the  minimum  local  analgesic 
concentration (MLAC) for bolus administration at the initiation of analgesia, this 
study assessed MLAC (infusion) for the maintenance of analgesia throughout the 
first  stage  of  labor.  MLAC  (infusion)  was  determined  using  the  up-down 
sequential  analysis  described by Dixon and Massey.  The MLAC (infusion)  of 
epidural  bupivacaine was 0.063% (95% confidence interval,  0.058-0.068) and 
0.019%  (95%  confidence  interval,  0.000-0.038)  in  the  IV  and  EPI  groups 
respectively. A continuous infusion of fentanyl was more than three times more 
potent  when administered by the epidural  than by the IV route.  This  marked 
increase in potency for the epidural route is highly suggestive for a predominantly 
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spinal mechanism of action for infused epidural fentanyl under the conditions of 
this study37. 
8. Epidural analgesia with 0.15% ropivacaine plus sufentanil 0.5 microgram 
ml-1  versus  0.10%  bupivacaine  plus  sufentanil  0.5  microgram  ml-1:  a  
double-blind comparison during labour38.
Combined  with  sufentanil  0.5  microgram/ml,  0.10%  bupivacaine  and  0.15% 
ropivacaine produce effective and equivalent analgesia during labour, with similar 
incidences of motor block38.  A double-blind, randomized, prospective study was 
performed in 140 parturients who requested epidural analgesia. After a lumbar 
epidural catheter had been placed, patients received either 0.10% bupivacaine 
plus  sufentanil  0.5  microgram ml-1  or  0.15% ropivacaine  plus  sufentanil  0.5 
microgram ml-1 followed by a continuous infusion. Additional boluses were used 
for inadequate levels of  analgesia.  Visual  analogue pain scores,  motor block, 
level of sensory block, supplementary boluses and main characteristics of labour 
were recorded. No differences were observed between the two groups for pain 
scores, total volume of anaesthetic solution used [59 (23) and 57 (24) ml in the 
bupivacaine and ropivacaine groups respectively],  duration of labour, mode of 
delivery, side-effects or satisfaction score. The incidence of motor block was not 
statistically different between the groups (54 and 69% in the bupivacaine and 
ropivacaine groups respectively, p = 0.07). However, when motor block occurred, 
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survival  analysis  showed that  it  occurred sooner  in  the course of  labour  with 
ropivacaine compared with bupivacaine (log rank test, p = 0.012)38. 
9. Single-dose intrathecal analgesia to control labour pain: is it  a useful  
alternative to epidural analgesia?39
Physicians practising modern obstetrics in rural and small urban centres might 
find single-dose intrathecal narcotics [ITN] as a useful alternative to parenteral or 
epidural analgesia for appropriately selected patients39.  To examine the safety 
and efficacy of single-dose spinal analgesia ITN during labour, MEDLINE was 
searched and the references of 2 systematic reviews and a meta-analysis were 
reviewed to find articles on obstetric analgesia and pain measurement. The 33 
articles selected included 14 studies, 1 meta-analysis, and 2 systematic reviews, 
all providing level I evidence. The literature supports use of ITN as a safe and 
effective  alternative  to  epidural  anaesthesia.  The recent  decrease in  rates  of 
episiotomies and use of forceps during deliveries means patients require less 
dense  perineal  anesthesia.  The  advantage  of  single-dose  ITN  is  that  fewer 
physicians and nurses are needed to administer it even though its safety and 
effectiveness are comparable with other analgesics.  Use of ITN is associated 
with a shorter first stage of labour and more rapid cervical dilation. A combination 
of  2.5  mg  of  bupivacaine,  25  microgram  of  fentanyl,  and  250  microgram of 
morphine intrathecally usually provides a 4-hour window of acceptable analgesia 
for patients without complications not anticipating protracted labour39. 
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10.  Case  report:  Successful  labour  epidural  analgesia  in  a  patient  with  
spinocerebellar ataxia40.
A favourable outcome was found to be associated with epidural analgesia in a 
parturient with spinocerebellar ataxia (SCA). A 34-yr-old patient, G2 P0, presented 
at  term  with  a  history  of  SCA since  the  age  of  22  characterized  by  slurred 
speech,  balance and gait  disturbances,  diplopia  and nystagmus.  Neurological 
examination revealed an unsteady, wide-based gait, nystagmus, mild dysarthria, 
moderate finger to nose ataxia,  absent reflexes in all  upper and lower limbs, 
sensory loss to vibration and temperature discrimination up to the level of both 
knees, and normal motor strength. The patient presented for induction of labour 
at 40 weeks and requested epidural analgesia, which was performed in the usual 
manner. Following a negative test dose of 3 mL of 2% lidocaine, a loading dose 
of  10  mL  of  0.125%  bupivacaine  was  administered,  and  maintenance  of 
analgesia was achieved with a mixture of bupivacaine 0.0625% and fentanyl 2 
microgram/mL. The patient required standard doses of the epidural mixture, and 
experienced  effective  analgesia  for  labour  and  delivery.  Her  recovery  was 
uneventful and no subsequent neurological deficit was detected up to two years 
after delivery40. 
After going through these references, we decided to compare the efficacy of a 
mobile  epidural  using  0.125%  bupivacaine  and  0.0002%  fentanyl  versus a 
conventional epidural using 0.25% bupivacaine for labour analgesia.
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MATERIALS AND METHODS
Study Centre
     Institute  of  social  obstetrics,  Kasturba Gandhi  Hospital,  Madras  Medical 
College, Chennai.
Study Design
       Randomised, Prospective, Comparative, Parallel group study.
Study Period
      August 2008 to November 2008.
Study Population
                      Fifty parturients who were admitted to the antenatal ward and 
who requested  pain relief  during labor  and who fulfilled  the  recruitment 
criteria were selected for the study. The procedure was explained to them in 
detail and written consent was obtained from them.
Ethical Requirement
                        The study was performed in accordance with the principles stated 
in the Declaration of Helsinki. Ethical approval of the study protocol was obtained 
from the Ethics Committee at the Institution before the study was undertaken.
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Informed Consent
                         Written informed consent was obtained from each patient in the 
prescribed format prior to performance of any study related procedures: before 
physical examination, laboratory screening or any other investigational procedure 
and before administration of  any study related medication.  The patients  were 
given full information about the nature, procedure and importance of the study.
 
Inclusion Criteria
 ASA Status I & II
 Females in the age group from 18 to 30 years
 Primigravida
 Adequate gynaecoid pelvis 
 Cervical dilatation less than 4 cm
Exclusion Criteria
 Patient refusal
 Patients with pregnancy induced hypertension, heart disease, anaemia 
and other complications of pregnancy
 Cervical dilatation greater than 4 cm
 Patients  who  received  systemic  opioids  within  4  hours  of  epidural 
request
 Coagulopathy
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 Patients  with  clinically  significant  renal,  hepatic,  cardiovascular, 
haematopoetic,  pulmonary,  gastrointestinal,  nervous  or  endocrine 
disorders 
 Patients unwilling or unable to comply with the study procedures
Study Procedures     
After  obtaining  approval  from  the  Institutional  Ethics  Committee  and  written 
informed consent, 50 women fulfilling the inclusion criteria who required epidural 
analgesia in labour were studied.
IV access was secured but no IV fluid load was given. The patients were shifted 
to the operation theatre for insertion of the epidural catheter in aseptic manner. 
An epidural catheter was sited at the second lumbar interspace using a standard 
midline technique with  an 18-gauge Tuohy needle.  Patients entered in to the 
study in a randomized order to receive one of the study treatments.
The procedure was clearly explained to the patient.  The visual analog scale was 
shown to them and interpretation of the scale explained in detail.  Anaesthesia 
machine was checked and all emergency airway equipments like laryngoscopes, 
blades of different sizes, endotracheal tubes, LMAs, oropharyngeal airways were 
kept ready.  An emergency drug tray containing all the emergency drugs was 
also kept ready. 
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Patient’s vital parameters like heart rate, blood pressure, respiratory rate 
and fetal heart rate were continuously monitored during the procedure.  The base 
line  values  were  recorded.  The  drugs  to  be  administered  epidurally  were 
prepared and stored in a sterile container.
Equipment
The  needles  used  for  both  groups  were  of  Vygon  make  (17G  Tuohy 
epidural needle and 19G epidural catheter)
Procedure
With  the  patient  in  left  lateral  position,  under  aseptic  precaution  L2-L3 
interspace  was  identified  and  skin  infiltration  was  done  with  1.5  ml  of  2% 
lignocaine.  Using a 17G Tuohy needle and ‘loss of resistance to air’ technique 
the epidural space was identified.
After confirmation by negative aspiration test 19G epidural catheter was 
inserted and 5 cms kept inside the epidural space.  The catheter was tapped 
firmly to the back.  The patient was turned to supine position.  After negative 
aspiration of blood and CSF the initial dose of LA solution given in divided doses. 
A standard epidural  test dose itself  will  result  in augmentation of motor 
blockade.  Further, addition of epinephrine to confirm intravascular placement is 
not reliable in active labor.  Hence test doses were done away with.  Rather the 
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bolus dose itself was given in divided doses with 5 mins interval checking for 
motor block after the first dose.
Epidural top-ups were not given till patient complained of pain or 
discomfort. With the catheter in place patients were shifted to the labor ward, 
where they were closely monitored till delivery.
PROCEDURE FOR GROUP–A 0.1% BUPIVACAINE WITH FENTANYL 
IV access 
Monitors
Technique:
An  epidural  catheter  was  sited  at  the  second  lumbar  interspace  using  a 
standard midline approach with loss of resistance technique
15 ml of 0.1% bupivacaine with  fentanyl  50 micrograms and maintained on 
maternal request with bolus doses of 10ml of 0.1% bupivacaine with fentanyl 2 
micrograms/ml 
PROCEDURE FOR GROUP B – 0.25% plain bupivacaine
IV access 
Monitors
Technique:
An epidural catheter was sited at the second lumbar interspace using a standard 
midline approach with loss of resistance technique
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15ml of 0.25% of plain bupivacaine and maintained with 10 ml bolus doses of 
0.25% plain bupivacaine
                              
PARAMETERS THAT WERE COMPARED
Analgesia was measured using visual analogue scores (VAS) on a 100 mm 
line.  Measurements  were  performed  every  10  minutes  until  analgesia  was 
established and at 30 min and 1 hr after the initial dose. Thereafter 2 hourly 
VAS were recorded until delivery.
Motor  Power  was assessed using a modified Bromage score 30 mins after 
each top-up and at each request to get out of bed (score 0 = no weakness, able 
straight leg raise against resistance,  1 = not able to straight leg raise, able to 
flex knee, 2 = unable to flex knee, able to flex ankle,   3 = unable to move lower 
limb.
Mode  of  delivery  was  recorded,  as  were  time  intervals  between  top-ups, 
duration of first and second stages of labour, and time from insertion of epidural 
until delivery.
Tolerability was assessed by checking for complications like dural  puncture, 
venous  puncture,  pruritus,  nausea,  vomiting,  rigor,  drowsiness,  urinary 
retention, hypotension, respiratory depression. 
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Statistical report
                   Data were analysed using SPSS 11.5. Descriptive analysis for non-
parametric  variables was expressed in  proportion  and parametric  variables in 
mean  and  standard deviation.  The treatment difference was assessed using  t  
test for independent samples for parametric variables and by Chi square test for 
non-parametric variables. Statistical significance was assessed using p at 0.05 
cut off or 95% confidence interval. (95% CI).
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RESULTS
                       A total of 180 patients were screened for the study. 50 patients 
who fulfilled the inclusion criteria were enrolled for the study and were divided in 
to two groups -
 GROUP A: 25 patients
 GROUP B: 25 patients
                         Patients were randomly allocated to groups A or B to receive 
either of the two study therapies –either epidural bolus administration of 0.1% 
bupivacaine with 0.0002% fentanyl (Group A) or epidural bolus administration of 
0.25% plain bupivacaine (Group B). All patients in both the groups completed 
the study. There were no drop outs in the study. The following flow chart explains 
the progress of participants through the trial.
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                           RANDOMIZATION
                  
PATIENTS SCREENED (180)
GROUP A
(25 PATIENTS)
DATA COLLECTION  
• QUALITY OF ANALGESIA (VAS)
• DURATION OF LABOUR
• MOTOR BLOCK (BROMAGE SCORE)
• TIME FROM EPIDURAL TO DELIVERY
• COMPLICATIONS
PATIENTS SELECTED (50)
GROUP B
(25 PATIENTS)
EPIDURAL BOLUS 
ADMINISTRATION OF 
0.1% BUPIVACAINE 
WITH 0.0002% 
FENTANYL
EPIDURAL BOLUS 
ADMINISTRATION OF 
0.25% 
PLAIN BUPIVACAINE
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PHYSICAL CHARACTERISTICS
 Physical characteristics like age, height and weight were comparable in both the 
groups.
AGE DISTRIBUTION
The age distribution in both groups are shown in the table below.
T  able   2- Age distribution  
Age distribution Group - A Group - B
< 20 9 10
20-30 16 15
Total 25 25
Mean ± SD 21.2000 ± 2.533 20.0800 ± 1.824
T-test value 1.79
P value
(Using Student T-test)
0.037
WEIGHT DISTRIBUTION
The distribution of weight in both the groups are shown in Table 2. The values 
are similar in both groups and are statistically comparable. The Student T test 
done on the values revealed no statistical significance.
T  able   3- W eight distribution  
Weight frequency Group - A Group - B
50-59 5 5
60-69 17 14
70-79 3 6
Mean ± SD 64.44 ± 5.58 64.68 ± 5.71
T-test value 0.15
P value
(Using Student T-test)
0.862 (Not Significant)
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HEIGHT DISTRIBUTION
The distribution of weight in both the groups are shown in Table 4. The values 
are similar in both groups and are statistically comparable. The Student T test 
done on the values revealed no statistical significance.
T  able   4- H eight distribution  
Height frequency Group - A Group - B
50-59 1 3
60-69 17 16
70-79 7 6
Total 25 25
Mean ± SD 158.32 ±  4.63 156.84 ± 5.93
T-test value 0.98
P value
(Using Student T-test)
0.317 (Not Significant)
MODE OF DELIVERY
One  patient  in  Group  A  and  two  patients  in  Group  B  were  delivered  by 
Caesarean section. The indication for Caesarean section was failure to progress 
in labour.  Two patients in Group B were delivered by outlet forceps delivery. The 
indication for forceps delivery was maternal exhaustion. All others were delivered 
by Labour Natural with episiotomy.
T  able   5- M ode of Delivery  
Mode of Delivery Group - A Group - B
Labour Natural 24 21
Caesarean section 1 2
Outlet forceps - 2
Chi-Square value 2.53333           
P value 0.28177 (Not Significant)
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Figure 3 - Mean age distribution
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F  igure   4- Duration of labour  
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TIME FROM EPIDURAL TO DELIVERY 
The time from epidural to delivery in both groups were comparable. The Student t 
test done on the values revealed no statistical significance.
T  able   6- Time from epidural to delivery  
Group No. of 
cases
Mean time from epidural 
to delivery in mins
SD Student t 
test
P value
Group A 24 161.8750 13.578
Group B 23 166.9565 13.878 
0.900 (Not 
Significant)
DURATION OF LABOUR
The total duration of labour in both groups were comparable. The duration of first 
and third stage of labour was comparable. Student T-test was done on duration 
on total  and each stage of labour.  The P-values were all  >0.05 implying that 
differences  were  not  statistically  significant.  Duration  of  the  second  stage  of 
labour was significantly shorter in group A (P =0.009).
T  able   7- Duration of labour  
Stage of 
Labour
Group - A Group - B
Mean 
(mins)
SD Mean 
(mins)
SD T-test P-value
First 
Stage
162.08 11.83 161.74 10.18 0.11 0.916
Second 
Stage
49.21 7.65 55.00   6.74 2.75 0.009**
Third 
Stage
16.67 4.08 16.96 3.91 0.25 0.805
Total 227.54 16.12 233.70 14.16 1.39 0.172
**- Denotes significance at 1% level and 5% level
Number of Top-ups
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F  igure   5- Number of top-ups  
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F  igure   6- Motor block- Bromage score  
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NUMBER OF TOP-UPS GIVEN
Number of top-ups given in both groups were comparable. The Chi-Square test 
done on the values revealed no statistical significance.
T  able   8- Number of top-ups  
No. of 
top-ups
Group – A Group - B
N % N %
1 0 0 0 0
2 10 40 10 40
3 15 60 15 60
4 0 0 0 0
Chi-Square 
value
0.00000           
P value 1.00000 (Not Significant)
MOTOR BLOCKADE
This was assessed using the Modified Bromage Scale. The patients in group A 
had minimal motor blockade when compared to patients in group B. The Chi-
Square  test  showed  statistical  significance  with  regard  to  motor  blockade 
between the two groups.
T  able   9- Motor block- Bromage score  
Bromage 
Scale
Group – A Group - B
N % N %
0 12 48 0 0
1 12 48 14 56
2 1 4 11 44
3 0 0 0 0
Chi-Square 
value
20.48718           
P value  0.00004 (Significant)
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VAS SCALE
The pain perceived by the patients was assessed by showing them a VAS scale 
which contained pictures of faces depicting pain on one end and smiling face on 
the other end. In between the two, there were pictures expressing intermediate 
emotions. The other side had a scale marked from 0 to 100. The scale had a 
slider  which  the  patients  move  to  point  below  the  image  which  they  felt 
expressed their perceived pain.
T  able   10- VAS score  
Time 
in 
mins
Group - A            Group - B Student t test
Mean Std 
Deviation
Mean Std 
Deviation
P value
0 94.00 7.07 94.00 7.07 1.000
5 57.60 11.65 56.80 10.69 0.794
15 11.60 8.50 15.40 7.90 1.000
30 0.20 1.00 5.80 5.72 0.000
45 10.20 6.20 13.00 6.45 0.102
60 12.20 8.05 13.60 7.43 0.847
120 11.40 10.16 12.80 8.55 0.787
180 9.00 4.79 11.80 4.54 0.707
The VAS score was assessed at 0, 5, 15, 30, 45, 60, 120 and 180 minutes. The 
initial VAS score ranged between 80 and 100 for all the patients. VAS score for 
pain was comparable in both groups throughout labour.
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Figure    8- Patient comfort level  
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PATIENT COMFORT LEVEL
This was assessed by asking the patient how they felt at the end of the delivery. 
Majority of patients (68%) in group A had excellent pain relief. 32% of patients in 
group A had good pain relief. In group B, 60% of patients had fair pain relief and 
40% of patients had good pain relief.
T  able   11- Patient comfort level  
Comfort 
level
Group – A Group - B
N % N %
1- Poor 0 0 0 0
2- Fair 0 0 15 60
3- Good 8 32 10 40
4- Excellent 17 68 0 0
Chi-Square 
value
32.2222          
P value < 0.001 (Significant)
UPPER SENSORY LEVEL
Patients in both groups had a mean sensory level of T9. The maximum was only 
T11 and minimum level was T8
T  able   12- Upper sensory level  
Sensory 
level
Group – A Group - B
N % N %
T6 0 0 0 0
T7 0 0 0 0
T8 5 20 6 24
T9 8 32 8 32
T10 7 28 8 32
T11 5 20 3 12
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HAEMODYNAMIC VARIABLES
All haemodynamic variables were recorded at 0 mins (baseline), 5 mins, 15 mins, 
30 mins, 45 mins, 60 mins and thereafter every 15 mins. For the purpose of 
statistical comparison after the first hour, only the hourly recording or that during 
every top-up was considered.
MATERNAL PULSE RATE
Pulse rate recordings were found to be comparable between the two groups.
The two way ANOVA test done on the pulse rate recordings showed no statistical 
difference between the two groups.
T  able   13- Maternal pulse rate  
Time in mins Group – A Group - B
Mean Std 
Deviation
Mean Std 
Deviation
0 90.26 11.14 91.44 9.57
2 92.43 9.65 93.28 9.57
5 91.48 12.11 89.36 7.20
15 91.83 9.44 89.12 7.66
30 90.87 6.20 86.40 6.03
45 90.09 6.59 85.84 4.93
60 89.74 8.10 87.60 3.61
2 hours 88.35 6.23 89.52 6.12
3 hours 88.48 9.12 89.76 2.07
Summary of ANOVA for 2X 10 factorial experiment with repeated measures 
on the second factor (10 times)
Sources 
of 
variation
Sum of 
square
DF Mean 
square
F value P value
Between 
drugs
174.68 1 174.68 0.39 0.53
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SYSTOLIC BLOOD PRESSURE
Systolic blood pressure were normal i.e) > 100 mm of Hg in both the groups and 
was not statistically significant between the groups.
T  able   14- Maternal systolic blood pressure  
Time in mins Group – A Group - B
Systolic 
blood 
pressure 
Mean
Std 
Deviation
Systolic 
blood 
pressure 
Mean
Std 
Deviation
0 116 6.455 115.84 7.116
5 113.6 9.074 114.4 8.210
15 112.4 7.141 111.12 6.685
30 112.72 7.414 111.84 7.701
45 108.88 7.096 112.4 6.481
60 112.16 7.369 111.12 6.483
2 hours 112.56 9.028 107.24 7.674
3 hours 108.36 7.658 112.40 7.000
Summary of ANOVA for 2X 9 factorial experiment with repeated measures 
on the second factor (9 times)
Sources 
of 
variation
Sum of 
square
DF Mean 
square
F value P value
Between 
drugs
16245 2 8122.5 5.871 0.553
With time 8415.4 7 1202.2 0.8689 0.141
The two way ANOVA test showed no significant statistical difference between the 
two groups and also with time.
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Figure   9- Maternal systolic blood pressure  
DIASTOLIC BLOOD PRESSURE
The two groups had no significant difference in the diastolic blood pressure as 
was seen in the systolic blood pressure. The two way ANOVA test showed no 
statistical difference between the two groups.
T  able   15- Maternal diastolic blood pressure  
Time in mins Group – A Group - B
Diastolic 
blood 
pressure 
Mean
Std 
Deviation
Diastolic 
blood 
pressure 
Mean
Std 
Deviation
0 75.52 4.665 76.16 4.394
5 75.62 4.605 75.28 4.468
15 75.44 5.116 75.68 5.558
30 74.80 4.619 76.0 4.761
45 75.12 4.438 74.56 5.523
60 75.12 4.868 73.56 4.142
2 hours 76.16 4.394 76.16 4.580
3 hours 75.28 4.686 76.40 4.435
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Summary of ANOVA for 2X 9 factorial experiment with repeated measures 
on the second factor (9 times)
Sources 
of 
variation
Sum of 
square
DF Mean 
square
F value P value
Between 
drugs
183.6 2 918.28 0.6980 0.5141
With time 9286.9 7 1326.7 1.008 0.4656
FOETAL HEART RATE
There was not much variation between the two groups and the ANOVA test did 
not show any statistical significance between the two groups.
T  able   16- Foetal heart rate  
Time in mins Group – A Group - B
mean foetal 
heart rate 
Std 
Deviation
mean foetal 
heart rate 
Std 
Deviation
0 142.17 8.65 142.24 15.66
5 140.87 11.08 145.28 6.29
15 138.87 7.16 151.00 6.01
30 142.26 6.16 146.00 8.10
45 145.65 7.92 142.92 4.64
60 145.22 9.74 146.72 4.58
2 hours 149.22 10.25 145.68 12.56
3 hours 144.70 12.19 152.88 5.23
Summary of ANOVA for 2X 9 factorial experiment with repeated measures 
on the second factor (9 times)
Sources 
of 
variation
Sum of 
square
DF Mean 
square
F value P value
Between 
drugs
945.96 1 945.96 7.3 0.08
APGAR SCORE
APGAR score estimated at one and five minutes are tabulated below.
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T  able   17- One minute APGAR  
APGAR Group – A Group - B
N % N %
5 0 0 0 0
6 2 8 5 20
7 11 44 6 24
8 12 48 14 56
9 0 0 0 0
10 0 0 0 0
P value by Chi square test did not show statistical difference.
                                T  able   18- Five minute APGAR  
APGAR Group – A Group - B
N % N %
5 0 0 0 0
6 0 0 0 0
7 0 0 2 8
8 18 72 15 60
9 5 20 8 32
10 2 8 0 0
P value by Chi square test did not show statistical difference.
COMPLICATIONS
Hypotension (SBP <90 mm Hg or < 30% of baseline) was present in one case 
each in both the groups. Both cases responded to 6 mg of Ephedrine IV. Pruritus 
was  present  in  one  case  each  in  both  the  groups.  It  was  only  mild  and 
reassurance was all that was needed. One patient in group B had vomiting.
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T  able   19- Complications  
COMPLICATION Group – A Group - B
Hypotension 1 1
Pruritus 1 1
Vomiting 0 1
Respiratory depression 0 0
Urinary retention 0 0
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DISCUSSION
 A number of methods exist to provide pain relief to the labouring parturient. Of 
the  regional  techniques,  epidural  analgesia  is  considered  the  gold  standard 
among all  other techniques and it  is  the only technique which  can provide a 
complete and convincing pain relief making labour a pleasurable experience41.
In our study, we have demonstrated that with an epidural top-up technique using 
0.1% bupivacaine with fentanyl 2 microgram /ml (group A) analgesia was similar 
to that using 0.25% plain bupivacaine (group B), but motor power was retained 
allowing women to mobilize.  There also appear to be beneficial effects on the 
progress  of  labour,  with  a  clinically  important  reduction  in  the  length  of  the 
second stage.
In our study, the patients in group A had minimal motor blockade when compared 
to patients in group B. This clinically significant motor blockade was supported 
statistically with a p-value of 0.00004 using chi-square test. Reduction in motor 
block allowing independent  movement and awareness of  contractions without 
pain  has been  shown  to  be  popular  with  mothers.   Retention  of  pelvic  floor 
sensation and motor function may allow appropriate coordinated pushing during 
the second stage, improving rotation and descent of the fetal head through the 
pelvis. Epidural local anaesthetic may attenuate endogenous oxytocin production 
reducing uterine contractility during the second stage. 
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Both a long second stage and instrumental delivery have associated morbidity for 
the  mother,  pose  a  controversial  potential  risk  to  the  baby  and  negatively 
influence maternal satisfaction with the experience of labour.  Although epidural 
analgesia  produces  excellent  analgesia,  this  does  not  automatically  produce 
maternal satisfaction with labour, and less effective methods of analgesia have 
produced  higher  satisfaction  with  scores.   We  demonstrated  high  maternal 
satisfaction  with  both  epidural  solutions,  which  was  significantly  greater  in 
bupivacaine-fentanyl group.
Analgesia was established by 30 min in all women.  Establishing analgesia with 
an epidural bolus is effective but takes longer than a combined spinal-epidural 
technique,  which  has  been  described  widely.   However,  it  avoids  the 
complications  of  deliberate  dural  puncture.   The  time  difference  between 
establishing spinal rather than epidural analgesia should be viewed in the context 
of the duration of labour and the potential complications of the spinal component 
of a combined technique.
The blood pressures (both systolic and diastolic) and pulse rate recorded during 
the analgesia in both the groups were not statistically significant. The APGAR 
score  observed  at  1  minute  and  5  minutes  showed  no  significant  neonatal 
depression.
Complications were only few, were minor and easily manageable.
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SUMMARY
In our study, comparison of epidural bolus administration of 0.25% bupivacaine 
and 0.1% bupivacaine with 0.0002% fentanyl  for  analgesia during labour was 
done. Patients were randomized to enter either group A treatment arm or group 
B  treatment  arm.  Group  A  received  bolus  doses  of  0.1%  bupivacaine  with 
fentanyl 2 micrograms/ml while group B received 0.25% plain bupivacaine. 
Analgesia provided by both techniques was found to be similar. Women in group 
A retained motor power in their legs. Motor Block was minimized in Group A.
Duration of labour and time from insertion of the epidural to delivery was similar 
in both groups, but in group A, duration of the second stage was significantly 
shorter. In addition, maternal satisfaction with epidural analgesia was higher in 
group A.
Both the treatment arms had lesser impact on the haemodynamics. 
Complications were only few, were minor and easily manageable.
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CONCLUSION
In our study, we have shown that establishing epidural analgesia in labour with 
15ml of 0.1% bupivacaine combined with fentanyl 50 microgram followed by top-
ups  of  10ml  of  0.1%  bupivacaine  with  0.0002%  fentanyl,  produced  similar 
analgesia to that obtained from the same volume of 0.25% bupivacaine alone, 
but  motor  block  was  minimized.   This  may influence the  progress  of  labour, 
decreasing  the  duration  of  the  second  stage  and  produce  high  maternal 
satisfaction with the experience of labour.
In our study, the APGAR score observed at 1 minute and 5 minutes showed no 
significant neonatal depression.
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APPENDICES
Appendix 1
Informed Consent Form-English
STUDY TITLE:
Labour Analgesia- A comparative study between epidural bolus administration of 0.1% 
bupivacaine with 0.0002% fentanyl and 0.25% plain bupivacaine
Study centre:
Patient name:
Patient age:
Identification no:
Patient may check (√) these
 
I confirm that I have understood the purpose of the procedure of the above study. I have had 
the opportunity to ask questions and all my questions and doubts have been answered to my 
complete satisfaction.
I understand that my participation in this study is voluntary and that I am free to withdraw at 
any time without giving any reason, without my legal rights being affected.
I understand that sponsor of the clinical study, others working on the sponsor’s 
behalf, the ethics committee and the regulatory authorities will not need my 
permission to look at my health records both in respect of the current study and any 
further research that may be conducted in relation to it, even if I withdraw from 
study. I agree to this access . However, I understand that my identity would not be 
revealed. In any information released to third parties or published, unless as 
required under the law. I agree not to restrict the use of any data or results that arise 
from this study.                     
I agree to take part in the above study and to comply with the instructions given 
during the study and to faithfully to cooperate with the study team, and to 
immediately  inform the  study staff if I suffer from any deterioration in my health or 
my wellbeing or any unexpected or unusual symptoms.
I hereby give consent to participate in the study “Labour Analgesia- A comparative study 
between epidural bolus administration of 0.1% bupivacaine with 0.0002% fentanyl and 
0.25% plain bupivacaine .”
I hereby give permission to undergo complete clinical examination, and diagnostic 
tests including hematological, biochemical, radiological and other investigation.
Signature /Thumb impression of the patient:
Place -                                                            
Date – 
Patient’s  Name and Address:
Signature of the Investigator:
Study Investigator’s Name:
Appendix 2
PROFORMA
“LABOUR ANALGESIA- COMPARISION OF EPIDURAL BOLUS ADMINISTRATION OF 0.1% 
BUPIVACAINE WITH 0.0002% FENTANYL VS 0.25% PLAIN BUPIVACAINE”
Name Height               :
Age Weight              :
Unit Gestational Age:
IPNo
Date of Study
Examination of Patient
PR : Urine: Albumin/sugar-
BP: Hb-
VS:
RS:
ASA Physical Status
Baseline status
• Visual analogue pain scale-
• Cervical dilatation-
• Foetal heart rate-
Parameters to be measured
Time for first painless Contraction
Motor Block (Bromage Score)
Time for onset for analgesia by skin prick
Upper sensory level
Time from epidural to delivery
Time between top-ups
Total Bupivacaine
Total Fentanyl
Quality of analgesia (VAS)
Duration of Labour 1st stage: 2nd stage: Total:
Complication
DuralPuncture
Venous Puncture
Pruritis
Nausea
Vomiting
Rigor
Drowsiness/sedation
Urinary retention
Hypotension
Respiratory depression

GROUP – A ---0.1% BUPIVACAINE WITH FENTANYL 2mcg/ml
S.No
. Name Age IP No
Weigh
t in kg
Height 
in cm
Gestationa
l age in 
weeks
Visual 
analogu
e pain 
scale
Cervical 
dilatatio
n in cm
Foetal 
heart 
rate/mi
n
Hb 
in 
gm
%
Urine 
-albumi
n
Urine 
-suga
r
1 Archana 19 14204 65 155 37 100 3 140 9.4 Nil Nil
2 Revathy 22 13987 55 160 37 90 4 140 9.6 Nil Nil
3
Sulochana 
Devi 18 14301 60 160 37 80 4 140 9.4 Nil Nil
4 Anitha 28 14199 52 152 37 100 4 140 9.8 Trace Nil
5 Ranjani 20 14323 60 155 37 100 3 130 9.8 Nil Nil
6 Jeya 24 14226 65 155 37 90 4 150 9.6 Nil Nil
7 Amudha 24 14366 58 155 37 100 3 126 10 Nil Nil
8
Raziya 
Begum 19 14378 64 158 38 80 4 136 10.4 Nil Nil
9 Geetha 24 14367 58 153 37 90 4 130 9.8 Nil Nil
10 Priya 20 14405 72 156 37 100 3 130 9.8 Nil Nil
11 Deepa 21 14402 69 163 37 100 4 130 10.6 Nil Nil
12 Baby 19 14392 68 165 37 80 3 130 9.6 Nil Nil
13 Seetha 18 14405 69 158 37 100 3 130 9.8 Nil Nil
14 Ambika 19 14279 75 160 37 90 3 140 9.2 Nil Nil
15 Gomathy 23 14417 68 165 37 100 3 120 9.6 Nil Nil
16 Nasheema 22 14420 62 148 36 90 4 130 9.6 Nil Nil
17 Vijayalakshmi 24 14430 64 158 36 90 3 140 9.4 Nil Nil
18 Kalaiyarasi 22 14435 70 159 37 100 4 130 9.8 Nil Nil
19 Sheela 23 14422 68 160 37 90 3 130 9.8 Nil Nil
20 Kalaimathi 20 14505 69 162 37 90 4 130 9.6 Nil Nil
21 Sangeetha 18 14519 69 164 37 100 4 126 9.4 Nil Nil
22
Muthulakshm
i 23 14526 62 156 37 90 3 128 9.4 Nil Nil
23 Devi 22 14524 59 152 37 100 4 125 9.8 Nil Nil
24 Usha 19 14575 68 165 37 100 4 130 9.6 Nil Nil
25 Esther Mary 19 14584 62 164 36 100 3 125 10 Nil Nil
GROUP – A ---0.1% BUPIVACAINE WITH FENTANYL 2mcg/ml
S.
N.
Name VAS scores (at minutes)
0 5 15 30 45 60 120 180 
Time for 
first 
painless 
Contractio
n in mins
 Bromag
e Score
Time for 
onset for 
analgesia 
in mins
Upper 
sensory 
level
Time-
epidural 
to 
delivery 
in mins
1 Archana 100 60 10 0 10 10 10 10 15 1 8 T9 120
2 Revathy 90 50 20 0 20 10 10 10 10 1 6 T9 140
3
Sulochana 
Devi 80 60 20 0 20 20 20 10 11 0 7 T10 160
4 Anitha 100 60 20 0 10 20 20 5 10 1 6 T10 160
5 Ranjani 100 60 0 0 5 5 5 5 11 0 7 T10 160
6 Jeya 90 40 10 0 0 5 10 10 11 1 7 T8 180
7 Amudha 100 60 10 0 0 5 5 5 13 1 8 T10 170
8 Raziya Begum 80 70 10 0 10 10 5 5 13 0 8 T11 180
9 Geetha 90 60 10 0 10 10 5 5 12 1 7 T8 170
10 Priya 100 40 10 5 30 10 5 5 12 0 8 T11 175
11 Deepa 100 60 0 0 10 10 10 10 12 0 8 T8 160
12 Baby 80 50 10 0 0 40 5 5 13 0 9 T10 180
13 Seetha 100 60 20 0 10 10 5 5 12 0 8 T9 170
14 Ambika 90 80 10 0 10 5 5 10 12 1 8 T11 150
15 Gomathy 100 60 20 0 10 5 5 5 13 0 8 T10 Nil
16 Nasheema 90 80 10 0 10 5 5 10 12 1 9 T8 165
17 Vijayalakshmi 90 60 0 0 10 10 5 10 12 0 8 T9 150
18 Kalaiyarasi 100 70 0 0 10 10 5 10 11 0 7 T8 160
19 Sheela 90 40 10 0 10 5 10 10 13 0 8 T9 170
20 Kalaimathi 90 70 0 0 10 10 10 10 13 1 8 T11 165
21 Sangeetha 100 40 0 0 10 20 50 20 15 1 8 T9 165
22 Muthulakshmi 90 40 20 0 10 10 10 10 11 1 7 T9 155
23 Devi 100 50 30 0 10 20 20 5 13 0 9 T11 150
24 Usha 100 60 20 0 10 20 25 25 13 1 8 T9 160
25 Esther Mary 100 60 20 0 10 20 20 10 12 2 8 T10 170
Time 
between 
top-ups 
in mins
Total 
Bupiva
caine 
mg
Total 
Fentan
yl µg
Comfort 
level
Duration of Labour in mins
1st 
stag
e
2nd 
stage 3rd stage Total Mode of delivery 
1 Archana 60 20 mg 60 3 140 50 10 200 LN
2 Revathy 65 20 mg 60 3 180 60 15 255 Labour naturale
3
Sulochana 
Devi 70 20 mg 60 4 160 45 15 220 Labour naturale
4 Anitha 45 30 mg 70 4 160 40 15 215 Labour naturale
5 Ranjani 45 30 mg 70 4 160 50 15 225 Labour naturale
6 Jeya 45 30mg  70 4 180 50 20 250 Labour naturale
7 Amudha 45 30mg 70 4 150 45 20 215 Labour naturale
8 Raziya Begum 50 30mg 70 4 150 50 20 220 Labour naturale
9 Geetha 60 20 mg 60 4 170 65 15 250 Labour naturale
10 Priya 50 30mg 70 3 170 60 20 250 Labour naturale
11 Deepa 60 20mg 60 4 180 50 20 250 Labour naturale
12 Baby 55 30mg 70 3 170 40 20 230 Labour naturale
13 Seetha 55 30mg 70 3 160 40 25 225 Labour naturale
14 Ambika 60 20 mg 60 4 150 40 20 210 Labour naturale
15 Gomathy 45 20 mg 60 3 NA NA NA NA Caeserean section
16 Nasheema 45 30 mg 70 3 154 56 15 225 Labour naturale
17 Vijayalakshmi 45 30 mg 70 4 148 60 20 228 Labour naturale
18 Kalaiyarasi 45 30 mg 70 4 172 45 10 217 Labour naturale
19 Sheela 50 30 mg 70 4 158 50 10 218 Labour naturale
20 Kalaimathi 50 30 mg 70 4 150 40 15 205 Labour naturale
21 Sangeetha 55 30 mg 70 4 150 45 10 205 Labour naturale
22 Muthulakshmi 60 20 mg 60 4 164 50 20 234 Labour naturale
23 Devi 60 20 mg 60 4 160 60 15 235 Labour naturale
24 Usha 60 20 mg 60 3 178 40 15 233 Labour naturale
25 Esther Mary 55 30 mg 70 4 176 50 20 246 Labour naturale
GROUP – A ---0.1% BUPIVACAINE WITH FENTANYL 2mcg/ml
S.No. Name
Maternal Systolic Blood Pressure in mg (at 
minutes)
Maternal Diastolic Blood Pressure in mg (at 
minutes)
0 5 15 30 45 60 120 180 0 5 15 30 45 60 120 180 
1 Archana 120 110 110 110 100 110 110 110 80 80 70 80 70 80 70 70
2 Revathy 110 110 120 110 120 100 110 120 70 60 80 70 80 70 70 80
3
Sulochana 
Devi 120 120 110 110 100 120 120 120 70 80 70 80 70 70 70 70
4 Anitha 120 110 80 90 90 120 110 100 80 70 50 60 60 80 70 80
5 Ranjani 120 110 110 100 120 120 120 120 80 80 60 70 70 80 88 80
6 Jeya 110 120 120 110 120 120 120 110 70 80 60 70 80 80 80 80
7 Amudha 110 120 120 110 120 120 110 110 70 80 70 70 80 70 70 70
8
Raziya 
Begum 120 120 110 120 130 120 120 110 70 80 60 70 80 70 60 70
9 Geetha 120 110 130 120 110 110 100 110 70 80 60 70 80 60 70 70
10 Priya 120 120 110 110 110 120 120 120 80 70 80 70 70 70 70 70
11 Deepa 110 110 120 110 110 120 100 110 70 80 70 60 70 80 70 70
12 Baby 120 120 130 110 110 120 120 120 70 80 80 80 70 70 80 80
13 Seetha 110 100 120 130 120 120 110 110 70 60 70 80 80 70 80 70
14 Ambika 110 120 120 120 110 120 110 106 70 80 60 70 70 70 80 70
15 Gomathy 120 110 100 120 100 110 120 120 70 70 80 70 60 70 80 70
16 Nasheema 110 120 110 120 100 130 130 120 70 80 80 70 70 80 80 70
17 Vijayalakshmi 110 130 120 120 130 120 110 110 70 80 60 70 70 80 70 70
18 Kalaiyarasi 120 110 120 120 110 120 120 110 70 80 80 70 80 70 70 80
19 Sheela 110 120 120 130 120 130 120 110 70 80 80 80 70 80 70 80
20 Kalaimathi 120 110 120 110 120 120 110 120 70 70 80 70 80 70 80 80
21 Sangeetha 120 110 120 110 110 120 120 120 80 70 80 80 70 70 80 70
22 Muthulakshmi 120 110 120 110 120 130 120 120 80 70 60 70 80 80 80 80
23 Devi 120 120 110 130 140 110 120 100 80 70 80 80 90 70 80 60
24 Usha 120 110 130 120 120 120 120 120 70 80 70 80 80 70 80 70
25 Esther Mary 120 110 110 120 130 120 100 110 80 70 70 80 80 70 60 70
GROUP – A ---0.1% BUPIVACAINE WITH FENTANYL 2mcg/ml
S.No. Name
Maternal pulse rate (at minutes) Foetal heart rate (at minutes)
0 5 15 30 45 60 120 180 0 5 15 30 45 60 120 180 
1 Archana 98 96 94 84 84 82 82 80 140 150 144 144 144 144 144 150
2 Revathy 94 92 90 84 86 84 82 80 152 148 144 144 144 146 144 142
3
Sulochana 
Devi 98 92 86 94 92 88 86 88 140 145 144 146 144 144 144 146
4 Anitha 90 88 89 90 88 84 88 86 150 140 145 146 144 142 130 140
5 Ranjani 80 84 82 86 94 94 94 94 140 150 144 144 144 144 142 140
6 Jeya 108 106 104 90 80 85 84 84 140 136 125 125 128 140 140 142
7 Amudha 108 104 80 80 76 84 82 82 126 132 125 140 130 130 130 130
8 Raziya Begum 108 106 90 88 86 84 80 84 136 125 140 145 130 140 130 135
9 Geetha 110 104 88 86 84 82 84 80 130 135 136 140 142 144 120 140
10 Priya 112 110 96 80 84 82 84 82 130 135 125 145 140 140 130 125
11 Deepa 120 120 114 116 90 86 84 86 130 140 120 125 128 134 144 142
12 Baby 104 102 96 98 90 80 82 82 130 125 130 120 140 125 130 135
13 Seetha 102 104 100 90 84 82 84 82 130 120 140 125 130 125 130 125
14 Ambika 104 102 94 90 86 80 84 82 140 130 145 145 130 130 145 120
15 Gomathy 88 86 84 82 84 80 82 84 120 125 126 130 125 125 130 135
16 Nasheema 104 102 104 102 88 84 86 84 130 135 140 125 130 125 130 130
17 Vijayalakshmi 106 104 88 84 82 80 84 80 140 145 130 135 120 120 130 135
18 Kalaiyarasi 102 104 90 88 88 84 82 84 130 128 135 120 125 125 130 135
19 Sheela 102 100 94 96 84 82 84 86 130 135 125 125 130 135 125 130
20 Kalaimathi 108 104 96 88 84 82 84 82 130 135 140 135 125 130 130 135
21 Sangeetha 101 100 96 94 80 82 76 78 126 128 135 110 140 130 135 125
22 Muthulakshmi 108 106 102 96 98 80 84 82 128 135 132 135 125 140 135 125
23 Devi 104 100 96 94 88 82 84 80 125 135 120 132 134 140 125 120
24 Usha 96 94 92 88 82 84 80 84 130 135 128 130 135 145 125 100
25 Esther Mary 112 106 102 96 80 84 82 86 120 125 130 135 120 140 135 140
GROUP – B--0.25% Plain BUPIVACAINE
S.No. Name Ag
e
IP 
No
Weigh
t in kg
Heigh
t in 
cm
Gestationa
l age in 
weeks
Visual 
analogu
e pain 
scale
Cervical 
dilatatio
n in cm
Foetal 
heart 
rate
min
Hb 
in 
gm
%
Urine 
-albu
min
Urin
e 
-sug
ar
1 Kanchana 25 13969 68 150 37 100 4 130 9.4 Nil Nil
2 Lakshmi 19 14075 66 156 37 100 3 100 9.8 Nil Nil
3 Saritha 19 14017 64 160 37 100 3 140 9.6 Nil Nil
4 Indumathy 21 13949 70 159 37 90 4 140 9.2 Nil Nil
5 Tajunisha 20 14079 68 159 37 100 4 140 9.8 Nil Nil
6 Sonia 19 14080 67 157 37 90 3 130 9.6 Nil Nil
7 Sangeetha 18 14052 72 160 37 90 4 90 10 Nil Nil
8 Shanthi 21 14084 74 162 37 100 3 140 10.4 Nil Nil
9 Valli 20 14068 64 158 37 90 4 140 9.2 Nil Nil
10 Tamilarasi 18 14077 69 159 37 90 4 144 9.6 Nil Nil
11 Bhavani 20 14118 63 170 37 100 4 156 9.8 Nil Nil
12 Suganya 18 14113 60 160 37 90 3 148 10.2 Nil Nil
13 Haj Sharmila 20 14087 62 153 37 100 4 140 10 Nil Nil
14 Kalaiselvi 22 14145 68 162 37 80 4 156 9.8 Nil Nil
15 Rajeshwari 23 14151 70 154 37 100 3 144 9.6 Trace Nil
16 Prema 18 14167 65 163 37 100 4 148 9.6 Nil Nil
17 Ayesha Begum 21 14197 70 162 37 90 4 140 9.8 Nil Nil
18 Vimala 18 14211 59 156 37 80 3 148 9.4 Nil Nil
19 Anitha 23 14209 73 144 37 100 4 140 10 Nil Nil
20
Barnees 
Susanna 20 14223 54 154 37 90 3 144 11 Nil Nil
21 Jeyalakshmi 20 14210 55 147 37 100 4 160 9.4 Nil Nil
22 Renuka 19 14245 59 152 37 100 3 148 9.8 Nil Nil
23 Nithya 21 14250 62 147 37 80 4 160 9.6 Nil Nil
24 Jeyachitra 18 14251 60 154 37 90 4 140 10.2 Nil Nil
25 Anandhi 21 14229 55 163 37 100 3 140 10.4 Nil Nil
S.No. Name
VAS scores (at minutes)
0 5 
1
5 
3
0 
4
5 60 120 180 
Time for 
first 
painless 
Contraction 
mins
 Bromag
e Score
Time for 
onset for 
analgesia 
in mins
Upper 
sensory 
level
Time 
from 
epidural
delivery 
mins
1 Kanchana 100 60 30 10 10 20 20 20 13 1 7 T10 175
2 Lakshmi 100 60 30 0 20 20 30 10 14 2 6 T8 165
3 Saritha 100 50 30 0 20 20 20 10 14 2 8 T9 155
4 Indumathy 90 40 25 10 20 20 10 10 12 1 7 T10 160
5 Tajunisha 100 40 10 0 10 20 40 20 16 2 8 T8 Nil
6 Sonia 90 70 10 0 10 10 10 20 14 2 6 T9 170
7 Sangeetha 90 40 20 0 20 10 10 10 12 1 7 T11 175
8 Shanthi 100 70 0 0 10 10 5 10 13 1 6 T9 165
9 Valli 90 60 10 0 10 10 5 15 13 2 8 T9 155
10 Tamilarasi 90 60 10 0 10 5 5 10 14 1 7 T8 170
11 Bhavani 100 60 20 10 10 10 20 10 13 1 7 T10 170
12 Suganya 90 80 10 10 10 5 5 10 13 2 8 T10 155
13
Haj 
Sharmila 100 60 20 10 10 10 5 5 14 1 8 T8 175
14 Kalaiselvi 80 50 10 10 10 40 10 10 13 1 6 T11 185
15 Rajeshwari 100 60 10 0 10 10 10 10 13 1 8 T9 Nil
16 Prema 100 40 10 5 30 10 10 10 13 1 9 T8 180
17
Ayesha 
Begum 90 60 10 0 10 10 5 5 14 2 9 T10 175
18 Vimala 80 70 10 20 20 10 10 10 14 1 7 T9 185
19 Anitha 100 60 10 10 0 10 10 10 12 2 8 T8 175
20
Barnees 
Susanna 90 40 10 10 5 10 20 20 12 1 8 T11 185
21 Jeyalakshmi 100 60 10 0 10 10 10 10 11 1 9 T9 165
22 Renuka 100 60 20 10 10 20 10 10 12 2 8 T10 165
23 Nithya 80 60 20 10 20 20 20 20 11 2 8 T10 165
24 Jeyachitra 90 50 20 10 20 10 10 10 16 2 9 T10 145
25 Anandhi 100 60 20 10 10 10 10 10 14 1 7 T9 125
GROUP – B--0.25% Plain BUPIVACAINE
S.No. Name Time 
between 
top-ups 
in mins
Total 
Bupivacaine
Total 
Fentanyl
Comfort 
level
Duration of Labour in mins
1st 
stage
2nd 
stage
3rd 
stage
Total
Mode of delivery 
1 Kanchana 55 30 mg Nil 2 175 55 20 250 Labour naturale
2 Lakshmi 60 20 mg Nil 3 175 45 15 235 Labour naturale
3 Saritha 55 20 mg Nil 3 160 65 15 240 Labour naturale
4 Indumathy 60 20 mg Nil 2 160 60 15 235 Labour naturale
5 Tajunisha 50 30 mg Nil 2 NA NA NA NA
Caeserean 
section
6 Sonia 55 30 mg Nil 2 150 55 20 225 Labour naturale
7 Sangeetha 55 30 mg Nil 3 150 50 10 210 Labour naturale
8 Shanthi 50 30 mg Nil 3 160 60 15 235 Labour naturale
9 Valli 50 30 mg Nil 3 170 55 10 235 Labour naturale
10 Tamilarasi 50 30 mg Nil 2 150 65 10 225 Forceps delivery
11 Bhavani 50 20 mg Nil 2 150 60 20 230 Labour naturale
12 Suganya 65 20 mg Nil 3 160 65 15 240 Labour naturale
13 Haj Sharmila 60 30 mg Nil 2 150 50 15 215 Labour naturale
14 Kalaiselvi 60 30 mg Nil 3 160 50 20 230 Labour naturale
15 Rajeshwari 65 20 mg Nil 2 NA NA NA NA
Caeserean 
section
16 Prema 55 30 mg Nil 2 170 50 25 245 Labour naturale
17 Ayesha Begum 65 20 mg Nil 2 180 60 20 260 Labour naturale
18 Vimala 55 30 mg Nil 2 170 65 20 255 Labour naturale
19 Anitha 50 30 mg Nil 2 170 60 20 250 Labour naturale
20
Barnees 
Susanna 50 30 mg Nil 3 150 50 15 215 Forceps delivery
21 Jeyalakshmi 50 30 mg Nil 2 150 45 20 215 Labour naturale
22 Renuka 50 30 mg Nil 2 180 55 20 255 Labour naturale
23 Nithya 75 20 mg Nil 2 160 50 20 230 Labour naturale
24 Jeyachitra 70 20 mg Nil 3 160 45 15 220 Labour naturale
25 Anandhi 65 20 mg Nil 3 160 50 15 225 Labour naturale
GROUP – B--0.25% Plain BUPIVACAINE
S.No. Name
Maternal Systolic Blood Pressure in mg (at 
minutes)
Maternal Diastolic Blood Pressure in mg (at 
minutes)
0 5 15 30 45 60 120 180 0 5 15 30 45 60 120 180 
1 Kanchana 110 120 110 100 110 110 120 110 70 80 70 80 70 80 70 70
2 Lakshmi 120 110 110 110 100 110 100 110 80 70 80 70 80 70 78 70
3 Saritha 110 130 100 100 110 100 110 110 80 78 70 80 70 80 80 80
4 Indumathy 130 120 100 100 120 110 100 100 80 80 60 80 70 80 70 80
5 Tajunisha 110 110 110 110 100 120 100 120 70 80 78 80 80 80 80 80
6 Sonia 120 100 120 120 110 130 120 100 78 70 80 80 70 80 70 70
7 Sangeetha 118 100 110 110 100 110 100 110 80 70 70 70 70 80 70 70
8 Shanthi 108 110 110 110 110 120 110 110 70 80 80 70 70 70 70 70
9 Valli 110 120 110 110 120 136 100 110 78 80 78 80 70 70 70 70
10 Tamilarasi 120 110 110 110 100 116 120 110 70 80 80 70 80 70 70 70
11 Bhavani 110 110 100 110 110 100 114 120 80 80 78 70 70 80 70 70
12 Suganya 130 100 110 110 100 110 110 110 70 80 70 70 80 70 70 70
13 Haj Sharmila 110 110 110 110 110 110 110 110 70 78 80 70 80 70 70 70
14 Kalaiselvi 120 110 100 118 120 100 120 120 70 80 70 70 82 70 70 70
15 Rajeshwari 110 100 120 120 100 110 100 120 70 82 78 80 80 70 70 70
16 Prema 110 110 110 100 110 120 110 108 80 80 80 80 80 70 70 70
17 Ayesha Begum 120 110 100 110 100 110 110 120 70 70 80 70 70 70 70 70
18 Vimala 110 110 120 110 100 120 110 129 70 80 70 80 72 70 70 70
19 Anitha 130 110 110 120 110 100 120 100 70 80 70 80 80 80 70 70
20
Barnees 
Susanna 110 130 110 110 110 110 110 110 80 80 76 70 80 80 70 70
21 Jeyalakshmi 110 110 110 100 100 110 100 120 78 70 78 70 82 80 70 70
22 Renuka 110 100 100 120 130 110 120 110 80 70 80 80 78 70 70 70
23 Nithya 110 110 110 110 110 100 110 100 70 78 86 80 80 80 72 72
24 Jeyachitra 110 120 100 100 110 108 120 100 70 70 70 80 80 80 78 78
25 Anandhi 110 110 110 120 110 100 110 110 80 70 70 80 80 80 72 78
GROUP – B--0.25% Plain BUPIVACAINE
S.No. Name
Maternal pulse rate (at minutes) Foetal heart rate (at minutes)
0 5 15 30 45 60 120 180 0 5 15 30 45 60 120 180 
1 Kanchana 70 84 80 84 84 80 70 80 130 140 150 158 170 140 140 140
2 Lakshmi 90 100 110 100 80 84 90 90 100 152 152 144 156 160 160 160
3 Saritha 90 96 90 90 90 90 92 92 140 152 140 144 144 160 152 152
4 Indumathy 90 96 90 90 90 90 92 90 140 144 140 144 144 140 152 152
5 Tajunisha 90 96 86 80 80 90 90 90 140 132 148 144 152 144 158 158
6 Sonia 86 90 90 92 96 90 90 90 130 146 140 110 152 130 160 160
7 Sangeetha 106 90 80 90 94 90 96 90 90 152 144 108 128 140 140 140
8 Shanthi 96 80 90 90 96 90 90 90 140 156 160 114 128 140 140 140
9 Valli 86 80 90 86 80 86 92 90 140 152 132 118 144 140 140 140
10 Tamilarasi 96 80 90 92 80 90 96 90 144 146 144 120 140 140 140 140
11 Bhavani 106 80 80 96 78 88 70 90 156 146 144 140 140 138 140 140
12 Suganya 110 96 80 80 80 96 90 90 148 160 140 160 140 140 138 138
13 Haj Sharmila 88 80 88 78 80 88 90 90 140 144 138 148 136 140 118 118
14 Kalaiselvi 86 82 82 80 78 82 92 92 156 140 140 110 140 140 120 120
15 Rajeshwari 70 88 80 80 80 84 88 90 144 139 140 100 140 140 128 128
16 Prema 72 90 82 86 80 88 90 90 148 148 140 110 140 140 110 110
17 Ayesha Begum 86 86 88 84 82 86 90 92 140 150 140 130 135 140 140 140
18 Vimala 86 88 88 86 80 88 84 90 148 148 140 130 140 140 130 130
19 Anitha 86 86 80 88 80 90 80 90 140 140 140 130 130 140 120 120
20
Barnees 
Susanna 88 78 80 80 83 82 88 80 144 140 140 130 140 130 130 130
21 Jeyalakshmi 80 80 110 114 82 80 72 80 160 140 140 130 140 140 130 130
22 Renuka 120 110 78 90 80 82 96 90 148 140 140 130 140 148 130 130
23 Nithya 114 106 80 90 80 86 90 80 160 140 140 130 140 130 130 130
24 Jeyachitra 114 110 80 88 80 88 92 88 140 150 150 140 140 136 146 140
25 Anandhi 108 109 80 86 80 86 78 90 140 140 150 140 136 140 140 146
